WO2007047111A1 - Coil assemblies, components and methods - Google Patents

Coil assemblies, components and methods Download PDF

Info

Publication number
WO2007047111A1
WO2007047111A1 PCT/US2006/038811 US2006038811W WO2007047111A1 WO 2007047111 A1 WO2007047111 A1 WO 2007047111A1 US 2006038811 W US2006038811 W US 2006038811W WO 2007047111 A1 WO2007047111 A1 WO 2007047111A1
Authority
WO
WIPO (PCT)
Prior art keywords
coil
embolic
coils
engaging member
catheter
Prior art date
Application number
PCT/US2006/038811
Other languages
French (fr)
Inventor
Marcia S. Buiser
Steve Keenan
Ashley Seehusen
Christopher Nardone
Original Assignee
Boston Scientific Scimed, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Scientific Scimed, Inc. filed Critical Boston Scientific Scimed, Inc.
Publication of WO2007047111A1 publication Critical patent/WO2007047111A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • A61B17/12113Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/1214Coils or wires
    • A61B17/12145Coils or wires having a pre-set deployed three-dimensional shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/1214Coils or wires
    • A61B17/1215Coils or wires comprising additional materials, e.g. thrombogenic, having filaments, having fibers, being coated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205Introduction devices
    • A61B2017/12054Details concerning the detachment of the occluding device from the introduction device

Definitions

  • the invention relates to embolic coil assemblies, as well as related components and methods.
  • Embolic coils can be used to occlude vessels in a variety of medical applications.
  • the invention relates to embolic coil assemblies, as well as related components and methods.
  • the invention features a coil assembly that includes at least first and second embolic coils.
  • the first embolic coil has an engaging member
  • the second embolic coil has an engaging member that is engaged with the engaging member of the first embolic coil.
  • the first embolic coil differs from the second embolic coil in at least one coil parameter.
  • the invention features coil assemblies that include three or more embolic coils.
  • Each of the three embolic coils has an engaging member at each end that is adjacent to another embolic coil.
  • the engaging members of each of the three embolic coils are engaged with an engaging member of an adjacent embolic coil.
  • At least one embolic coil differs from at least one other embolic coil in at least one coil parameter.
  • the invention features a method that includes inserting a coil assembly into a body lumen of a subject.
  • the coil assembly includes at least first and second embolic coils.
  • the first embolic coil has an engaging member
  • the second embolic coil has an engaging member that is engaged with the engaging member of the first embolic coil.
  • the first embolic coil differs from the second embolic coil in at least one coil parameter.
  • the invention features a method that includes inserting a coil assembly into a body lumen of a subject.
  • the coil assembly includes three or more embolic coils. Each of the three embolic coils has an engaging member at each end that is adjacent to another embolic coil.
  • the engaging members of each of the three embolic coils are engaged with an engaging member of an adjacent embolic coil.
  • At least one embolic coil differs from at least one other embolic coil in at least one coil parameter.
  • the invention features a method of deploying embolic coils to a site.
  • the methods include placing a distal end of a catheter at the site; pushing a coil assembly including at least two (e.g., at least three) embolic coils to the distal end of the catheter; and deploying at least two embolic coils in the coil assembly out of the catheter to the site.
  • At least one embolic coil differs from at least another embolic coil in at least one coil parameter.
  • Embodiments can include one or more of the following.
  • the coil parameter can be selected from length, inner diameter, outer diameter, stiffness, secondary shape, and degree of fiber coverage.
  • the coil assembly can include additional embolic coils (e.g., a third, a fourth, a fifth, or more embolic coils), one or more of which may include engaging members for engaging with engaging members of adjacent embolic coils.
  • additional embolic coils e.g., a third, a fourth, a fifth, or more embolic coils
  • the coil assembly can include a sleeve at least partially surrounding the first and second embolic coils, and optionally any additional embolic coils.
  • the engaging member of an embolic coil e.g., the first embolic coil
  • the engaging member of an adjacent embolic coil e.g., the second embolic coil
  • the assembly can be configured such that movement of the second embolic coil in a proximal or distal direction results in movement of the first coil in the same direction.
  • the assembly can include a pusher wire.
  • the pusher wire can include an engaging member (e.g., at the distal end of the pusher wire) that is capable of engaging with an engaging member of an adjacent embolic coil.
  • the embolic coils can be deployed by pushing the coil assembly distally until the distal-most embolic coil (e.g., the first embolic coil) is pushed fully out of the catheter or sleeve, where it disengages from the adjacent embolic coil (e.g., the second embolic coil), optionally repositioning the catheter or sleeve, and then pushing the coil assembly distally until the adjacent embolic coil is pushed fully out of the catheter, where it disengages and is deployed.
  • the distal-most embolic coil e.g., the first embolic coil
  • the adjacent embolic coil e.g., the second embolic coil
  • the method can include pushing each of the embolic coils distally out of the catheter or sleeve such that they disengage and deploy, optionally with repositioning of the catheter occurring between coil deployments.
  • One or more of the embolic coils can be pushed partially out of the catheter and then at least partially retracted back into the catheter, e.g., for repositioning.
  • the method can include determining appropriate coil parameters for treatment of the particular defect (e.g., a vascular defect) and selecting at least first and second embolic coils that have the appropriate coil parameters.
  • Embodiments can include one or more of the following advantages.
  • multiple embolic coils can be disposed within a subject without removing the pusher wire from the subject. This can reduce the complexity, e.g., by reducing the number of steps, and/or enhance the precision of disposing one or more embolic coils within a subject.
  • multiple embolic coils can be disposed within a subject using a continuous process. This can reduce the complexity, e.g., by reducing the number of steps, and/or enhance the precision of disposing one or more embolic coils within a subject.
  • multiple embolic coils can be disposed within a subject with a single push of the pusher wire. This can reduce the complexity, e.g., by reducing the number of steps, and/or enhance the precision of disposing one or more embolic coils within a subject.
  • At least one of the multiple embolic coils can differ from at least one other multiple embolic in a coil parameter, such as, for example, length, outer diameter, stiffness, secondary shape, and degree of fiber coverage.
  • a coil parameter such as, for example, length, outer diameter, stiffness, secondary shape, and degree of fiber coverage.
  • One or more of the embolic coils can be selected based on the desired use of the embolic coil(s).
  • the order of the embolic coils can also be selected based on the desired use of the embolic coils. For example, each embolic coil can be selected and/or ordered so that the multiple embolic coils as a collection form a particular configuration when disposed within the subject.
  • FIG. 1 is a cross-sectional view of an embodiment of a coil assembly.
  • FIG. 2 A is a cross-sectional view of an embodiment of a coil assembly illustrating disengagement of the most distal embolic coil.
  • FIG. 2B is a perspective view of an embodiment of a secondary shape mandrel
  • FIG. 3 A is a perspective view of an embodiment of an embolic coil.
  • FIG. 3B is a perspective view of an embodiment of an embolic coil.
  • FIG. 3 C is a perspective view of an embodiment of an embolic coil.
  • FIG. 3D is a perspective view of an embodiment of an embolic coil.
  • FIG. 3E is a perspective view of an embodiment of an embolic coil.
  • FIG. 3F is a perspective view of an embodiment of an embolic coil.
  • FIG. 3G is a perspective view of an embodiment of an embolic coil.
  • FIG. 3H is a perspective view of an embodiment of an embolic coil.
  • FIG. 4A is a side view of an embodiment of engaging member.
  • FIG. 4B is a perspective view of the embodiment of FIG. 4A.
  • FIG. 4C is a partial cross-sectional view of an embodiment of a coil assembly.
  • FIG. 5 A is a side view of an embodiment of engaging member.
  • FIG. 5B is a perspective view of the embodiment of FIG. 5 A.
  • FIG. 5C is a partial cross-sectional view of an embodiment of a coil assembly.
  • FIG. 6 is a partial cross-sectional view of an embodiment of a coil assembly.
  • FIG. 7A is a partial cross-sectional view of an embodiment of a coil assembly.
  • FIG. 7B is a side view of an embodiment of engaging member.
  • FIG. 8 is a cross-sectional side view of an embodiment of a coil assembly, introducer sheath and catheter.
  • FIGS. 9A-C illustrate an embodiment of a method.
  • FIGS. 10A- 1OC illustrate an embodiment of a method. Like reference symbols in the various drawings indicate like elements.
  • FIG. 1 shows an embolic coil delivery system 8, which includes a sleeve 10, in this case a catheter.
  • An embolic coil assembly 14 is disposed within a lumen 12 in catheter 10.
  • Embolic coil assembly 14 includes a first embolic coil 16 having a distal end 18, a proximal end 20, and an engaging member 22 at the proximal end 20.
  • Embolic coil assembly 14 further includes a second embolic coil 26 having a distal end 28, a proximal end 30, and engaging members 22 at each end.
  • a pusher wire 46 includes an engaging member 22 at distal end 48.
  • the engaging member 22 of the first embolic coil 16 is engaged with the adjacent engaging member 22 of the second embolic coil 26. Further, the engaging member 22 at the proximal end 30 of the second embolic coil 26 is engaged with the engaging member 22 of the pusher wire 46. In such an arrangement, the pusher wire 46 can be used to move the embolic coil assembly 14 either proximally or distally within the catheter 10.
  • the embolic coils 16 and 26 differ from each other in at least one coil parameter.
  • the embolic coils may differ from each other in secondary shape.
  • embolic coils have a primary shape and a secondary shape.
  • the primary shape refers generally to the shape of the coil when constrained within the sleeve.
  • the primary shape of an embolic coil generally depends on a number of coil parameters, including, for example, the composition, shape, size, and stiffness of the wire which forms the coil (or braid, where the embolic coil is a braided coil), the outer diameter of the coil, the inner diameter of the coil, and the length of the coil.
  • the secondary shape of an embolic coil refers to the shape of the coil when it is not constrained by the sleeve.
  • an embolic coil exits the sleeve it can assume its secondary shape.
  • the secondary shape of an embolic coil depends on the process by which the coil was formed, particularly the shape of the mandrel on which the coil was formed and the heat treatment cycle used to shape the coil.
  • a secondary shape mandrel 34 shown in FIG. 2B, can be used to form a primary coil into a secondary shape.
  • the secondary shape mandrel 34 includes a chuck 35 for connecting the mandrel to a device holds the mandrel steady and optionally rotates the mandrel (e.g., a drill).
  • the mandrel 34 includes three shaping locations 36 that have a substantially diamond-shaped cross section.
  • a groove 38 is disposed about the shaping locations 36 to form a continuous, diamond-shaped helix.
  • a primary coil can be positioned in the groove 38 and wound around the shaping locations 36, and subject to a heat cycle to impart the helical diamond shape into the coil.
  • the heat cycle can include, for example, elevating the coil to a temperature of from about 1025° F to about 1300° F (e.g., 1100° F) for a period of time from about 20 minutes to about 40 minutes (e.g., about 30 minutes) to impart the secondary shape into the coil.
  • An embolic coil shaped by one of the shaping locations 36 would represent the diamond-shaped helical coil 54 illustrated in FIG. 3 C, described below.
  • the secondary shape mandrel is typically formed of a material capable of withstanding the heat cycle to which the coil will be subjected without significantly softening or changing shape, e.g., stainless steel.
  • the mandrel 34 can include any number of shaping locations and can simultaneously accommodate multiple embolic coils (e.g., at least 4 coils, at least 8 coils, at least 12 coils, or at least 16 coils).
  • the secondary shape imparted by each of the shaping locations can be the same, or can vary.
  • Other coil parameters play a role in the secondary shape of an embolic coil.
  • Examples of such parameters include the composition, shape, size and stiffness of the wire which forms the coil, the inner and/or outer diameter and the length of the coil, the uniformity of the windings of the coil, the pitch of the primary coil windings, and/or the spacing of the primary coil windings.
  • the primary shape is selected for deliverability and the secondary shape is selected for the application, e.g., the embolization of an aneurysm.
  • the embolic coils can have any number of secondary shapes, the choice of which can depend on the particular application in which the embolic coil is to be used.
  • the secondary shape of a first embolic coil and of a second embolic coil can each be independently selected from the group consisting of helical or spiral dual-spiral, dual-diameter spiral, diamond, cone- shaped, random, basket-shaped, straight, C-shaped and J-shaped.
  • one coil can be have a secondary shape in the form of a basket, while a different coil has a secondary shape in the form of a J.
  • one coil can have a helical secondary shape, while a different coil has a diamond or a conical secondary shape.
  • Exemplary secondary shapes are illustrated in FIGS. 3A- 3H.
  • FIG. 3 A shows an embolic coil 50 with a spiral secondary shape, which can be used, e.g., to provide a supportive framework along a vessel wall and/or to hold other embolic coils that are subsequently delivered to the target site.
  • FIG. 3 A shows an embolic coil 50 with a spiral secondary shape, which can be used, e.g., to provide a supportive framework along a vessel wall and/or to hold other embolic coils that are subsequently delivered to the target site.
  • FIG. 3B shows an embolic coil 52 with a vortex or conical secondary shape, which can be used, e.g., to close the center of a target site such as a vessel or an aneurysm that is to be occluded, optionally in conjunction with an embolic coil or coils, for example, a coil of a different secondary shape.
  • embolic coil 54 can have a diamond secondary shape which can be utilized in a fashion similar to coil 52.
  • FIG. 3D shows a dual-spiral secondary shape 55 in which two conical shapes 56 and 57 meet at their smaller ends.
  • FIG. 3E shows an embolic coil 58 with secondary shape in the form of a J, which can be used, for example, to fill remaining space in an aneurysm not filled by other coils.
  • FIG. 3 F shows an embolic coil 62 with a secondary shape in the form of a spiral having a first section 63 with a first helical diameter and a second section 64 with a second helical diameter.
  • Such a coil can be used, for example, to provide a supportive framework along a vessel wall and simultaneously occlude or partially occlude the vessel and/or hold other embolic coils that are subsequently delivered to the target site.
  • FIG. 3 G shows an embolic coil 66 having a basket-shaped secondary shape, which can be used, for example, to frame an aneurysm and/or hold or provide a support for other embolic coils that are subsequently delivered to the target site.
  • Any of the shapes just described can be achieved using a braided embolic coil; for example, FIG. 3 H shows a braided embolic coil 68 having a secondary shape in the form of a C, which may be used, e.g., in filling an aneurysm.
  • these secondary shapes are approximations, and that the coils may be, for example, a diamond-shape or substantially a diamond shape.
  • Secondary shapes include random or tangled, generally spherical or spheroid, generally elliptical, clover-shaped, box-shaped. Also included are three-dimensional shapes such as these in which a single coil frames the shape and fills or partially fills the shape.
  • a spherical-shaped coil could have a generally spherical coil frame and be partially filled by the same coil that forms the frame.
  • the embolic coils may differ in length. Suitable coil lengths generally include lengths of, e.g., at least about 2 cm long (e.g., at least about 8 cm long, at least about 15 cm long, or at least about 20 cm long) and/or at most about 30 cm long (e.g., at most about 20 cm long, at most about 15 cm long, or at most about 8 cm long).
  • a coil can, for example, be from about 2 cm to about 30 cm long (e.g., from about 2 cm to about 8 cm long, from about 8 cm to about 15 cm long, from about 15 cm to about 20 cm long, or from about 20 cm to about 30 cm long).
  • the length of an embolic coil refers to the length of the embolic coil while restrained in a sleeve (i.e. the length of the coil in its primary configuration or shape).
  • a total coil length (the combined length of all of the embolic coils) of about 30 cm split into one 10 cm coil and ten 2 cm coils; two 5 cm coils and ten 2 cm coils; two 10 cm coils and two 5 cm coils; two 10 cm coils and five 2 cm coils; and three 5 cm coils and five 3 cm coils.
  • the restrained (primary) coil length of an embolic coil may be related to the secondary shape of the coil.
  • a diamond- shaped coil can have a length of no more than about 80 mm (e.g., no more than about 60 mm or no more than about 40 mm) and/or can have a length of no less than about 20 mm (e.g., no less than about 40 mm or no less than about 60 mm).
  • a diamond shaped coil can in some embodiments have a length of from about 20 mm to about 80 mm (e.g., from about 40 mm to about 60 mm).
  • a spiral-shaped coil can have a length of no more than about 70 mm (e.g., no more than about 60 mm, no more than about 50 mm, no more than about 40 mm, no more than about 30 mm, or no more than about 20 mm) and/or can have a length of no less than about 10 mm (e.g., no less than about 20 mm, no less than about 30 mm, no less than about 40 mm, no less than about 50 mm, or no less than about 60 mm).
  • a spiral-shaped coil can in some embodiments have a length from about 10 to about 70 mm (e.g., from about 20 mm to about 60 mm or from about 30 mm to about 50 mm).
  • a straight coil can have a length of no more than about 10 mm (e.g., no more than about 7 mm, no more than about 5 mm, or no more than about 3 mm) and/or can have a length of no less than about 2 mm (e.g., no less than about 3 mm, no less than about 5 mm, or no less than about 7 mm).
  • a straight coil can in some embodiments have a length of from about 2 mm to about 10 mm (e.g., from about 3 mm to about 7 mm).
  • a C-shaped coil can have a length of no more than about 10 mm (e.g., no more than about 7 mm, no more than about 5 mm, or no more than about 3 mm) and/or can have a length of no less than about 2 mm (e.g., no less than about 3 mm, no less than about 5 mm, or no less than about 7 mm).
  • a C- shaped coil can in some embodiments have a length of from about 2 mm to about 10 mm (e.g., from about 3 mm to about 7 mm).
  • a J-shaped coil can have a length of no more than about 30 mm (e.g., no more than about 25 mm, no more than about 20 mm, or no more than about 15 mm) and/or can have a length of no less than about 10 mm (e.g., no less than about
  • a J-shaped coil can in some embodiments have a length of from about 10 mm to about 30 mm (e.g., from about 15 mm to about 25 mm).
  • a vortex- shaped or conical-shaped coil can have a length of no more than about 70 mm (e.g., no more than about 67 mm, no more than about 53 mm, or no more than about 35 mm) and/or can have a length of no less than about 30 mm (e.g., no less than about 35 mm, no less than about 53 mm, or no less than about 67 mm).
  • a vortex-shaped or conical-shaped coil can in some embodiments have a length of from about 30 mm to about 70 mm (e.g., from about 35 mm to about 67 mm or from about 35 mm to about 53 mm).
  • the length of any one coil can be no more than about 80 mm (e.g., no more than about 70 mm, no more than about 60 mm, no more than about 50 mm, no more than about 40 mm, no more than about 30 mm, no more than about 20 mm, no more than about 10 mm, or no more than about 5 mm) and/or can be no less than about 0.5 mm (e.g., no less than about 5 mm, no less than about 10 mm, no less than about 20 mm, no less than about 30 mm, no less than about 40 mm, no less than about 50 mm, no less than about 60 mm, or no less than about 70 mm).
  • 80 mm e.g., no more than about 70 mm, no more than about 60 mm, no more than about 50 mm, no more than about 40 mm, no more than about 30 mm, no more than about 20 mm, no more than about 10 mm, or no more than about 5 mm
  • 0.5 mm e.
  • the length of any one coil can be from about 0.5 mm to about 80 mm (e.g., from about 5 mm to about 70 mm, from about 10 mm to about 60 mm, from about 20 mm to about 50 mm, or from about 30 mm to about 40 mm), hi some embodiments, the length of all the coils, in total, can be no more than about 60 cm (e.g., no more than about 50 cm, no more than about 40 cm, no more than about 30 cm, no more than about 20 cm, no more than about 10 cm, or no more than about 8 cm). Generally, the length of the coils, in total, is selected in part to prevent the amount of force used to push the coil assembly from becoming too large.
  • the coils may differ in the diameter of the wire from which they are formed.
  • the coils may be formed of wire, e.g., platinum, platinum/tungsten alloy or stainless steel wire, having a diameter of between about 0.001 inch to about 0.005 inch in diameter.
  • One coil may be formed of wire having a diameter of between about 0.001 inch to about 0.0025 inch in diameter, while another coil may be between about 0.003 inch to about 0.005 inch in diameter.
  • the difference in wire diameter can result in a difference in the outer diameter of the first coil and second coil (taken in their primary shapes), given a constant inner diameter of the first and second coils.
  • the outer diameter of one of the first coil and second coil may be between about 0.013 inch to about 0.015 inch and the other of the first coil and second coil may be between about 0.010 inch to about 0.012 inch while sharing a constant inner diameter.
  • the outer diameter of the coils may differ regardless of the inner diameter of the coils.
  • the outer diameter of a coil refers to the outer diameter of the coil when in its secondary configuration.
  • the outer diameter of the coils can be no more than about 14 mm (e.g., no more than about 12 mm, no more than about 10 mm, no more than about 8 mm, no more than about 6 mm, no more than about 4 mm, or no more than about 2 mm) and/or can be no less than about 1 mm (e.g., no less than about 2 mm, no less than about 4 mm, no less than about 6 mm, no less than about 8 mm, no less
  • the outer diameter of the embolic coils can be from about 1 mm to about 14 mm (e.g., from about 2 mm to about 12 mm, from about 4 mm and to about 10 mm, or from about 6 mm and to about 8 mm).
  • one embolic coil can have an outer diameter no more than about 6 mm (e.g., no more than about 5 mm, no more than about 4 mm, no more than about 3 mm, or no more than about 2 mm) while another embolic coil can have an outer diameter of not less than about 8 mm (e.g., not less than about 10 mm or not less than about 12 mm).
  • the stiffness of the coils may be varied. It will be recognized that certain other parameters will affect the stiffness of the coils, for example, the composition and the diameter of the wire from which the coil is formed.
  • the diameter of a mandrel around which the coil is formed (in other words, the inner diameter of the coil) may affect the stiffness.
  • additional treatment of the coil once formed can affect the stiffness. For example, subjecting a coil to heat and then cooling the coil may result in stiffening of the coil.
  • Coil stiffness may vary between about 0.001 lbf and about 0.004 lbf. Coil stiffness can be measured by measuring the force required to compress the outer coil 5% of the main secondary coil diameter.
  • a dynamic testing machine such as is available from Instron Corp., can be utilized to test coil stiffness.
  • a main outer diameter of a secondary coil is removed from the secondary coil and placed in the gripping mechanism of the testing machine such that only half of the diameter (a semi-circle shape) is exposed.
  • the sample is placed directly below an anvil-like fixture that compresses down on the surface of the outer diameter. The force required to compress the sample by 5% of the overall main outer diameter is measured.
  • the embolic coils may include fibers.
  • Exemplary fiber materials include polyethylene terephthalate (e.g., Dacron ® ), nylon, collagen and/or cotton fibers, which may promote thrombosis by providing a substrate for clot formation.
  • the degree of fiber coverage may be varied.
  • some of the embolic coils may have fibers while others do not.
  • the embolic coils may each have fibers but have different amounts of fibers for a given length of coil.
  • the fibers may be, for example, of the same or different length (generally between about 0.5 mm to about 5 mm), stiffness, and/or diameter.
  • the spacing between fiber bundles and the fiber densities i.e.
  • one coil can have bundles having greater numbers of fibers than a different coil but have the bundles spaced farther apart, resulting in the same number of fibers per length of coil but a different distribution of fiber coverage on each coil.
  • the embolic coil delivery systems can include more than two embolic coils (e.g., three or more, four or more, five or more, or six or more embolic coils). In such embodiments, at least two of the embolic coils differ from each other in at least one coil parameter. In certain embodiments, three or more, four or more, five or more, or six or more embolic coils can differ from each other in at least one coil parameter; further, the coil parameters that differ may be the same coil parameter or may be two or more different coil parameters (e.g., three or more, four or more, five or more, or six or more different coil parameters).
  • the embolic coils generally include at least one engaging member for engaging with an adjacent embolic coil, and may optionally include two engaging members for engaging with adjacent embolic coils or pusher wires one either side of the embolic coil.
  • the engaging members generally are configured such that one member reversibly accepts a portion of a corresponding member.
  • Configurations include an engaging member having an open receiving slot generally perpendicular to the longitudinal axis of the coil and corresponding engaging member having a hook adapted to enter and exit an open receiving slot generally perpendicular to the longitudinal axis of the coil, and also include engaging members having an outer portion of a generally cylindrical shape, a middle portion adapted to accept a generally cylindrical outer portion of an adjacent corresponding engaging member, and an inner portion adapted for attaching to the coil (where “outer” refers to the portion of the engaging member distant from the coil to which it is attached and “inner” refers to the portion nearest the coil).
  • the engaging member of one end of a coil may be, but need not be, the same as the engaging member at a different end of the coil, where the coil has two engaging members.
  • Each coil and each engaging member may further include a channel or lumen extending longitudinally, with a control wire extending through the channels to further engage the coils.
  • FIGS. 4A and 4B show side and perspective views, respectively, of an embodiment of an engaging member 160.
  • Engaging member 160 is generally cylindrical in shape with a surface 162 which may be cut or milled away to allow the surface to mesh with receiving area 164 on an adjacent engaging member.
  • Connecting end 166 is adapted to be connected to an embolic coil or pusher wire, and may be any suitable shape, e.g., cylindrical.
  • Vertical mating surface 168 is adapted to meet a similar vertical mating face on an adjacent engaging member to allow one engaging member to pull the other when the first engaging member is pulled, while end surface 170 pushes against mating surface 167 when the first engaging member is pushed.
  • FIGS. 4C shows a pair of engaging members as described in FIGS. 4A and 4B when engaged, in this case engaging a pusher wire 178 and an embolic coil 180.
  • FIGS. 5 A, 5B and 5C show an interlocking member 172 having an end surface 174 that is ramped. This design can, for example, permit assembly ease in placing the coils into a catheter or introducer sheath.
  • an embolic coil assembly may also include a control wire.
  • the control wire can permit the coils to remain engaged until the control wire is removed and the coil is not constrained by a catheter or introducer sleeve. For example, FIGS.
  • FIGS. 7A and 7B show an embolic coil assembly 130 in which a coil 128 is engaged with a pusher wire 130 by engaging members 132 in combination with a control wire 106.
  • Each engaging member 132 includes a ramped face 136 with a slot 138 and a longitudinally-extending passageway 140 for receiving control wire 106.
  • Control wire 106 extends through lumens 131 and 133 in the pusher wire 130 and in coil 128, respectively.
  • Engaging members 132 cannot disengage, even when unconstrained by a sleeve, until control wire 106 is pulled out of opening 141 of channel 140.
  • FIG. 8 illustrates an embolic coil assembly delivery system in which an embolic coil assembly 202 is contained in an introducer sleeve 204 which is separate from catheter 210.
  • the introducer sleeve 204 includes a locking portion 206, e.g., a portion of the introducer sleeve that has been twisted under heat to deform and grip the pusher wire and/or coil assembly, to lock a pusher wire 224 and/or coil assembly 202 in sleeve 204. This may prevent the coil assembly from moving longitudinally in the sleeve and possibly out of the sleeve before such is desired.
  • Such a locking portion can be unlocked, e.g., by untwisting the sheath, to allow the pusher wire/coil assembly to move freely.
  • the catheter 210 is first inserted into a body lumen of a subject, for example, through an incision into the femoral artery, and moved through the body until its distal end is at a target location, for example, the opening of an aneurysm.
  • a distal tip 206 of sleeve 204 is placed into a hub 216 attached to a proximal end 212 of the catheter and the embolic coil assembly is pushed by means of pusher wire 224 into catheter 210 and to the distal end of the catheter for delivery to the target site.
  • the pusher wire is then used to push the embolic coil assembly out of the distal tip of the catheter such that individual coils disengage from the assembly and deploy into the target area.
  • the pusher wire may be used to hold the coil assembly in place while the catheter is retracted, thus permitting self-disengagement of individual coils.
  • a control wire may be retracted either before or after pushing the coils out of the catheter or retracting the catheter.
  • FIGS . 9 A-C illustrate an embodiment of a method for treatment of an aneurysm.
  • a catheter 510 is inserted into the body and guided through a lumen 502 in a vessel 500 to an opening 506 in an aneurysm 504.
  • An embolic coil assembly 514 is inserted into the catheter for deployment into the aneurysm.
  • Embolic coil assembly 514 includes a long coil 536 with an engaging member 522 at a proximal end 540 and two shorter coils 516 and 526, each having engaging members 522 at each end. The coils are selected to accomplish particular tasks with respect to treating the aneurysm.
  • long coil 536 is selected of a sufficient length and secondary shape to frame the embolism to add strength and prevent the aneurysm from rupturing, to begin sealing off the opening 506, and to provide a framework to which shorter coils 516, 526 can attach themselves.
  • Shorter coils 516, 526 have a secondary shape in the form of a J to enable each to be hooked onto this framework and are sufficiently flexible to enable them to pack together densely to fill the voids in the aneurysm.
  • the J- shaped coils will themselves be long (e.g., from about 15 mm to about 30 mm) as well as soft and flexible. This can enable a physician to custom fill vessels or aneurysms as desired to achieve a desired density of packing.
  • a pusher wire 546 with an engaging member 522 at its distal end 548 is engaged to coil 526.
  • the pusher wire is used to push embolic coil assembly 514 to the distal end 511 of catheter 510 so that the long coil 536 extends partially out of the catheter.
  • the long coil 536 begins to assume its secondary shape as it exits the catheter. At this point, should repositioning be desired, the embolic coil assembly 514 can be retracted into the catheter by pulling back on the pusher wire 546.
  • embolic coil assembly 514 is pushed sufficiently far distally that the long coil 536 passes entirely out of catheter 510, disengages and assumes its secondary basket shape and frames the aneurysm. At this point, the catheter 510 can be left in position and the remaining coils 516, 526 can be deployed. As seen in FIG. 9C, embolic coils 516 and 526 have a secondary shape in the form of a J to hook onto the long coil 536 and extend into and fill voids in the aneurysm.
  • the pusher wire 546 need not be withdrawn to permit insertion of the additional coils. This may provide for shorter times of treatment and/or less movement of materials through the catheter, given the lack of a requirement for removing the pusher wire, inserting a J-shaped coil, reinserting the pusher wire and pushing the coil to the distal tip of the catheter, and may lead to superior results.
  • FIGS. lOA-C show the occlusion of a vessel 600, with a long coil 636 having a helical secondary shape being first deployed (FIG. 1OA, 10B), followed by a first coil 616 having a secondary shape in the form of a C that can, for example, hook itself into the helical coil 636, and followed by second coil 626 having a secondary shape in the form of a J such that, for example, the hooked portion of the J shape can attach itself to the helical coil and the straight portion can extend into the opening to occlude the vessel 600.
  • Additional coils could be added to the embolic coil assembly, such as coils having as secondary shapes diamonds, vortexes or the like to better occlude the central part of the vessel and interweave themselves with the helical coil.
  • some or all of the embolic coils in the embolic coil assembly may have secondary shapes other than those disclosed above.
  • other suitable secondary shapes, and methods for creating embolic coils having such shapes are discussed in U.S. Patents 4,994,069, 6,231,586, 6,322,576 and 6,635,069, each of which is hereby incorporated by reference.
  • one or more of the embolic coils may include a coating, e.g., a polymer coating, for example, a lubricous coating, that may reduce friction between the coil and the catheter and allow for easier pushing of the coil.
  • a coating e.g., a polymer coating, for example, a lubricous coating
  • one or more coils may further include a therapeutic substance, e.g., a drug, for delivery to the target site along with the coil.
  • a therapeutic substance e.g., a drug
  • the embolic coils may differ in more than one coil parameter, for example, two, three, four, five or more coil parameters may be different.
  • more than two of the embolic coils may differ in one or more coil parameters, for example, three, four, five, or more coils, even each of the coils, may differ from each other in one or more coil parameters.
  • At least one of the embolic coils may be made in whole or in part of helical wire.
  • At least one of the coils may be made in whole or in part of braided wire.
  • At least one of the coils may include a radiopaque marker, which may consist of or be a part of the engaging member.
  • At least one of the embolic coils may be formed of a polymer, e.g., a biocompatible polymer.
  • a polymer e.g., a biocompatible polymer.
  • Exemplary polymers include polyethylene, polyurethane, and polypropylene.
  • engaging members have been described as being generally cylindrical in cross-sectional shape, the engaging members may have other configurations, for example, pentagonal or hexagonal. Also, the engaging members may have different engaging configurations than those disclosed above.
  • Other suitable engaging members are described in U.S. Patents 5,250, 071, 5,304,195, 5,800,453, 5,800,455, 5,891,130, 5,925,059, 6,099,546, RE37,117 E 5 and in WO 94/06503, each of which is hereby incorporated by reference.
  • a saline flush can be used to deliver an embolic coil from the sleeve rather than, or in addition to, the pusher wire.
  • embolic coils can be used in conjunction with other embolic devices.
  • Other embolic devices include, for example, embolic particles such as those described in U.S. Published Patent Application No. 2003/0185896 Al, published on October 2, 2003, and in U.S. Published Patent Application No. US 2004/0096662 Al, published on May 20, 2004, each of which are hereby incorporated by reference.
  • Other embolic devices also include, for example, embolic gels such as described, for example, in U.S.
  • embolic coils may be used to treat a variety of conditions.
  • embolic coils may be used generally to treat neurological and/or peripheral conditions such as to occlude a vessel or to treat an aneurysm, an arteriovenous malformation (AVM), or a traumatic fistula.
  • Embolic coils can be used to embolize a tumor, for example, a liver tumor.
  • Embolic coils can be used in transarterial chemoembolization (TACE).

Abstract

Coil assemblies and related components and methods are disclosed. The coil assemblies can include two or more embolic coils having one or more different coil parameters.

Description

Coil Assemblies, Components and Methods
TECHNICAL FIELD
[0001] The invention relates to embolic coil assemblies, as well as related components and methods.
BACKGROUND
[0002] Embolic coils can be used to occlude vessels in a variety of medical applications.
SUMMARY
[0003] The invention relates to embolic coil assemblies, as well as related components and methods.
[0004] In one aspect, the invention features a coil assembly that includes at least first and second embolic coils. The first embolic coil has an engaging member, and the second embolic coil has an engaging member that is engaged with the engaging member of the first embolic coil. The first embolic coil differs from the second embolic coil in at least one coil parameter.
[0005] In another aspect, the invention features coil assemblies that include three or more embolic coils. Each of the three embolic coils has an engaging member at each end that is adjacent to another embolic coil. The engaging members of each of the three embolic coils are engaged with an engaging member of an adjacent embolic coil. At least one embolic coil differs from at least one other embolic coil in at least one coil parameter.
[0006] In a further aspect, the invention features a method that includes inserting a coil assembly into a body lumen of a subject. The coil assembly includes at least first and second embolic coils. The first embolic coil has an engaging member, and the second embolic coil has an engaging member that is engaged with the engaging member of the first embolic coil. The first embolic coil differs from the second embolic coil in at least one coil parameter. [0007] In an additional aspect, the invention features a method that includes inserting a coil assembly into a body lumen of a subject. The coil assembly includes three or more embolic coils. Each of the three embolic coils has an engaging member at each end that is adjacent to another embolic coil. The engaging members of each of the three embolic coils are engaged with an engaging member of an adjacent embolic coil. At least one embolic coil differs from at least one other embolic coil in at least one coil parameter.
[0008] In another aspect, the invention features a method of deploying embolic coils to a site. The methods include placing a distal end of a catheter at the site; pushing a coil assembly including at least two (e.g., at least three) embolic coils to the distal end of the catheter; and deploying at least two embolic coils in the coil assembly out of the catheter to the site. At least one embolic coil differs from at least another embolic coil in at least one coil parameter.
[0009] Embodiments can include one or more of the following.
[0010] The coil parameter can be selected from length, inner diameter, outer diameter, stiffness, secondary shape, and degree of fiber coverage.
[0011] The coil assembly can include additional embolic coils (e.g., a third, a fourth, a fifth, or more embolic coils), one or more of which may include engaging members for engaging with engaging members of adjacent embolic coils.
[0012] The coil assembly can include a sleeve at least partially surrounding the first and second embolic coils, and optionally any additional embolic coils. The engaging member of an embolic coil (e.g., the first embolic coil) can remain engaged with the engaging member of an adjacent embolic coil (e.g., the second embolic coil) when constrained by the sleeve, and can be capable of disengaging from the engaging member of the adjacent embolic coil when unconstrained by the sleeve. [0013] The assembly can be configured such that movement of the second embolic coil in a proximal or distal direction results in movement of the first coil in the same direction.
[0014] The assembly can include a pusher wire. The pusher wire can include an engaging member (e.g., at the distal end of the pusher wire) that is capable of engaging with an engaging member of an adjacent embolic coil.
[0015] The embolic coils can be deployed by pushing the coil assembly distally until the distal-most embolic coil (e.g., the first embolic coil) is pushed fully out of the catheter or sleeve, where it disengages from the adjacent embolic coil (e.g., the second embolic coil), optionally repositioning the catheter or sleeve, and then pushing the coil assembly distally until the adjacent embolic coil is pushed fully out of the catheter, where it disengages and is deployed. Where there are additional embolic coils, the method can include pushing each of the embolic coils distally out of the catheter or sleeve such that they disengage and deploy, optionally with repositioning of the catheter occurring between coil deployments. One or more of the embolic coils can be pushed partially out of the catheter and then at least partially retracted back into the catheter, e.g., for repositioning. The method can include determining appropriate coil parameters for treatment of the particular defect (e.g., a vascular defect) and selecting at least first and second embolic coils that have the appropriate coil parameters.
[0016] Embodiments can include one or more of the following advantages.
[0017] In some embodiments, multiple embolic coils can be disposed within a subject without removing the pusher wire from the subject. This can reduce the complexity, e.g., by reducing the number of steps, and/or enhance the precision of disposing one or more embolic coils within a subject.
[0018] In certain embodiments, multiple embolic coils can be disposed within a subject using a continuous process. This can reduce the complexity, e.g., by reducing the number of steps, and/or enhance the precision of disposing one or more embolic coils within a subject.
[0019] In some embodiments, multiple embolic coils can be disposed within a subject with a single push of the pusher wire. This can reduce the complexity, e.g., by reducing the number of steps, and/or enhance the precision of disposing one or more embolic coils within a subject.
[0020] In certain embodiments, at least one of the multiple embolic coils can differ from at least one other multiple embolic in a coil parameter, such as, for example, length, outer diameter, stiffness, secondary shape, and degree of fiber coverage. One or more of the embolic coils can be selected based on the desired use of the embolic coil(s). Optionally, the order of the embolic coils can also be selected based on the desired use of the embolic coils. For example, each embolic coil can be selected and/or ordered so that the multiple embolic coils as a collection form a particular configuration when disposed within the subject.
[0021] Other features and advantages are apparent from the description, drawings and claims.
DESCRIPTION OF DRAWINGS
FIG. 1 is a cross-sectional view of an embodiment of a coil assembly.
FIG. 2 A is a cross-sectional view of an embodiment of a coil assembly illustrating disengagement of the most distal embolic coil. FIG. 2B is a perspective view of an embodiment of a secondary shape mandrel
FIG. 3 A is a perspective view of an embodiment of an embolic coil.
FIG. 3B is a perspective view of an embodiment of an embolic coil.
FIG. 3 C is a perspective view of an embodiment of an embolic coil.
FIG. 3D is a perspective view of an embodiment of an embolic coil. FIG. 3E is a perspective view of an embodiment of an embolic coil.
FIG. 3F is a perspective view of an embodiment of an embolic coil.
FIG. 3G is a perspective view of an embodiment of an embolic coil. FIG. 3H is a perspective view of an embodiment of an embolic coil.
FIG. 4A is a side view of an embodiment of engaging member.
FIG. 4B is a perspective view of the embodiment of FIG. 4A.
FIG. 4C is a partial cross-sectional view of an embodiment of a coil assembly. FIG. 5 A is a side view of an embodiment of engaging member.
FIG. 5B is a perspective view of the embodiment of FIG. 5 A.
FIG. 5C is a partial cross-sectional view of an embodiment of a coil assembly.
FIG. 6 is a partial cross-sectional view of an embodiment of a coil assembly.
FIG. 7A is a partial cross-sectional view of an embodiment of a coil assembly. FIG. 7B is a side view of an embodiment of engaging member.
FIG. 8 is a cross-sectional side view of an embodiment of a coil assembly, introducer sheath and catheter.
FIGS. 9A-C illustrate an embodiment of a method.
FIGS. 10A- 1OC illustrate an embodiment of a method. Like reference symbols in the various drawings indicate like elements.
DETAILED DESCRIPTION
[0022] FIG. 1 shows an embolic coil delivery system 8, which includes a sleeve 10, in this case a catheter. An embolic coil assembly 14 is disposed within a lumen 12 in catheter 10. Embolic coil assembly 14 includes a first embolic coil 16 having a distal end 18, a proximal end 20, and an engaging member 22 at the proximal end 20. Embolic coil assembly 14 further includes a second embolic coil 26 having a distal end 28, a proximal end 30, and engaging members 22 at each end. A pusher wire 46 includes an engaging member 22 at distal end 48.
[0023] The engaging member 22 of the first embolic coil 16 is engaged with the adjacent engaging member 22 of the second embolic coil 26. Further, the engaging member 22 at the proximal end 30 of the second embolic coil 26 is engaged with the engaging member 22 of the pusher wire 46. In such an arrangement, the pusher wire 46 can be used to move the embolic coil assembly 14 either proximally or distally within the catheter 10. The catheter
10 prohibits disengagement of the engaged embolic coils 16 and 26 while they are constrained by the catheter 10. As illustrated in FIG. 2 A, when embolic coil assembly 14 is moved distally such that the engaging member 22 at the proximal end 20 of the first embolic coil 16 is no longer constrained by the catheter 10, the first embolic coil 16 disengages from the second embolic coil 26 and is deployed. Similarly, the second embolic coil 26 can be so deployed.
The embolic coils 16 and 26 differ from each other in at least one coil parameter. For example, the embolic coils may differ from each other in secondary shape. In general, embolic coils have a primary shape and a secondary shape. The primary shape refers generally to the shape of the coil when constrained within the sleeve. The primary shape of an embolic coil generally depends on a number of coil parameters, including, for example, the composition, shape, size, and stiffness of the wire which forms the coil (or braid, where the embolic coil is a braided coil), the outer diameter of the coil, the inner diameter of the coil, and the length of the coil. The secondary shape of an embolic coil refers to the shape of the coil when it is not constrained by the sleeve. As an embolic coil exits the sleeve it can assume its secondary shape. In general, the secondary shape of an embolic coil depends on the process by which the coil was formed, particularly the shape of the mandrel on which the coil was formed and the heat treatment cycle used to shape the coil.
For example, a secondary shape mandrel 34, shown in FIG. 2B, can be used to form a primary coil into a secondary shape. The secondary shape mandrel 34 includes a chuck 35 for connecting the mandrel to a device holds the mandrel steady and optionally rotates the mandrel (e.g., a drill). The mandrel 34 includes three shaping locations 36 that have a substantially diamond-shaped cross section. A groove 38 is disposed about the shaping locations 36 to form a continuous, diamond-shaped helix. A primary coil can be positioned in the groove 38 and wound around the shaping locations 36, and subject to a heat cycle to impart the helical diamond shape into the coil. The heat cycle can include, for example, elevating the coil to a temperature of from about 1025° F to about 1300° F (e.g., 1100° F) for a period of time from about 20 minutes to about 40 minutes (e.g., about 30 minutes) to impart the secondary shape into the coil. An embolic coil shaped by one of the shaping locations 36 would represent the diamond-shaped helical coil 54 illustrated in FIG. 3 C, described below. The secondary shape mandrel is typically formed of a material capable of withstanding the heat cycle to which the coil will be subjected without significantly softening or changing shape, e.g., stainless steel. The mandrel 34 can include any number of shaping locations and can simultaneously accommodate multiple embolic coils (e.g., at least 4 coils, at least 8 coils, at least 12 coils, or at least 16 coils). The secondary shape imparted by each of the shaping locations can be the same, or can vary.
[0025] Other coil parameters play a role in the secondary shape of an embolic coil. Examples of such parameters include the composition, shape, size and stiffness of the wire which forms the coil, the inner and/or outer diameter and the length of the coil, the uniformity of the windings of the coil, the pitch of the primary coil windings, and/or the spacing of the primary coil windings.
Typically, the primary shape is selected for deliverability and the secondary shape is selected for the application, e.g., the embolization of an aneurysm.
[0026] The embolic coils can have any number of secondary shapes, the choice of which can depend on the particular application in which the embolic coil is to be used. For example, the secondary shape of a first embolic coil and of a second embolic coil can each be independently selected from the group consisting of helical or spiral dual-spiral, dual-diameter spiral, diamond, cone- shaped, random, basket-shaped, straight, C-shaped and J-shaped. As an example, in some of the embodiments, one coil can be have a secondary shape in the form of a basket, while a different coil has a secondary shape in the form of a J. As another example, in certain embodiments one coil can have a helical secondary shape, while a different coil has a diamond or a conical secondary shape. Exemplary secondary shapes are illustrated in FIGS. 3A- 3H. For example, FIG. 3 A shows an embolic coil 50 with a spiral secondary shape, which can be used, e.g., to provide a supportive framework along a vessel wall and/or to hold other embolic coils that are subsequently delivered to the target site. FIG. 3B shows an embolic coil 52 with a vortex or conical secondary shape, which can be used, e.g., to close the center of a target site such as a vessel or an aneurysm that is to be occluded, optionally in conjunction with an embolic coil or coils, for example, a coil of a different secondary shape. As shown in FIG. 3 C, embolic coil 54 can have a diamond secondary shape which can be utilized in a fashion similar to coil 52. FIG. 3D shows a dual-spiral secondary shape 55 in which two conical shapes 56 and 57 meet at their smaller ends. FIG. 3E shows an embolic coil 58 with secondary shape in the form of a J, which can be used, for example, to fill remaining space in an aneurysm not filled by other coils. Optionally, a curved portion
59 of embolic coil 58 can be hooked by the operator (e.g., a physician) into a coil or coil mass that has already been deployed at the target site, with a straight part 60 of embolic coil 58 optionally extending into open space to fill the target site. FIG. 3 F shows an embolic coil 62 with a secondary shape in the form of a spiral having a first section 63 with a first helical diameter and a second section 64 with a second helical diameter. Such a coil can be used, for example, to provide a supportive framework along a vessel wall and simultaneously occlude or partially occlude the vessel and/or hold other embolic coils that are subsequently delivered to the target site. FIG. 3 G shows an embolic coil 66 having a basket-shaped secondary shape, which can be used, for example, to frame an aneurysm and/or hold or provide a support for other embolic coils that are subsequently delivered to the target site. Any of the shapes just described can be achieved using a braided embolic coil; for example, FIG. 3 H shows a braided embolic coil 68 having a secondary shape in the form of a C, which may be used, e.g., in filling an aneurysm. It should be noted that these secondary shapes are approximations, and that the coils may be, for example, a diamond-shape or substantially a diamond shape. Other secondary shapes include random or tangled, generally spherical or spheroid, generally elliptical, clover-shaped, box-shaped. Also included are three-dimensional shapes such as these in which a single coil frames the shape and fills or partially fills the shape. For example, a spherical-shaped coil could have a generally spherical coil frame and be partially filled by the same coil that forms the frame.
[0027] In certain embodiments, the embolic coils may differ in length. Suitable coil lengths generally include lengths of, e.g., at least about 2 cm long (e.g., at least about 8 cm long, at least about 15 cm long, or at least about 20 cm long) and/or at most about 30 cm long (e.g., at most about 20 cm long, at most about 15 cm long, or at most about 8 cm long). A coil can, for example, be from about 2 cm to about 30 cm long (e.g., from about 2 cm to about 8 cm long, from about 8 cm to about 15 cm long, from about 15 cm to about 20 cm long, or from about 20 cm to about 30 cm long). As used here, the length of an embolic coil refers to the length of the embolic coil while restrained in a sleeve (i.e. the length of the coil in its primary configuration or shape).
[0028] Thus possible coil configurations include, for example, a total coil length (the combined length of all of the embolic coils) of about 30 cm split into one 10 cm coil and ten 2 cm coils; two 5 cm coils and ten 2 cm coils; two 10 cm coils and two 5 cm coils; two 10 cm coils and five 2 cm coils; and three 5 cm coils and five 3 cm coils. The restrained (primary) coil length of an embolic coil may be related to the secondary shape of the coil. For example, a diamond- shaped coil can have a length of no more than about 80 mm (e.g., no more than about 60 mm or no more than about 40 mm) and/or can have a length of no less than about 20 mm (e.g., no less than about 40 mm or no less than about 60 mm). A diamond shaped coil can in some embodiments have a length of from about 20 mm to about 80 mm (e.g., from about 40 mm to about 60 mm).
As another example, a spiral-shaped coil can have a length of no more than about 70 mm (e.g., no more than about 60 mm, no more than about 50 mm, no more than about 40 mm, no more than about 30 mm, or no more than about 20 mm) and/or can have a length of no less than about 10 mm (e.g., no less than about 20 mm, no less than about 30 mm, no less than about 40 mm, no less than about 50 mm, or no less than about 60 mm). A spiral-shaped coil can in some embodiments have a length from about 10 to about 70 mm (e.g., from about 20 mm to about 60 mm or from about 30 mm to about 50 mm). As another example, a straight coil can have a length of no more than about 10 mm (e.g., no more than about 7 mm, no more than about 5 mm, or no more than about 3 mm) and/or can have a length of no less than about 2 mm (e.g., no less than about 3 mm, no less than about 5 mm, or no less than about 7 mm). A straight coil can in some embodiments have a length of from about 2 mm to about 10 mm (e.g., from about 3 mm to about 7 mm). As another example, a C-shaped coil can have a length of no more than about 10 mm (e.g., no more than about 7 mm, no more than about 5 mm, or no more than about 3 mm) and/or can have a length of no less than about 2 mm (e.g., no less than about 3 mm, no less than about 5 mm, or no less than about 7 mm). A C- shaped coil can in some embodiments have a length of from about 2 mm to about 10 mm (e.g., from about 3 mm to about 7 mm). As another example, a J-shaped coil can have a length of no more than about 30 mm (e.g., no more than about 25 mm, no more than about 20 mm, or no more than about 15 mm) and/or can have a length of no less than about 10 mm (e.g., no less than about
15 mm, no less than about 20 mm, or no less than about 25 mm). A J-shaped coil can in some embodiments have a length of from about 10 mm to about 30 mm (e.g., from about 15 mm to about 25 mm). As another example, a vortex- shaped or conical-shaped coil can have a length of no more than about 70 mm (e.g., no more than about 67 mm, no more than about 53 mm, or no more than about 35 mm) and/or can have a length of no less than about 30 mm (e.g., no less than about 35 mm, no less than about 53 mm, or no less than about 67 mm). A vortex-shaped or conical-shaped coil can in some embodiments have a length of from about 30 mm to about 70 mm (e.g., from about 35 mm to about 67 mm or from about 35 mm to about 53 mm).
In general, the length of any one coil can be no more than about 80 mm (e.g., no more than about 70 mm, no more than about 60 mm, no more than about 50 mm, no more than about 40 mm, no more than about 30 mm, no more than about 20 mm, no more than about 10 mm, or no more than about 5 mm) and/or can be no less than about 0.5 mm (e.g., no less than about 5 mm, no less than about 10 mm, no less than about 20 mm, no less than about 30 mm, no less than about 40 mm, no less than about 50 mm, no less than about 60 mm, or no less than about 70 mm). In some embodiments, the length of any one coil can be from about 0.5 mm to about 80 mm (e.g., from about 5 mm to about 70 mm, from about 10 mm to about 60 mm, from about 20 mm to about 50 mm, or from about 30 mm to about 40 mm), hi some embodiments, the length of all the coils, in total, can be no more than about 60 cm (e.g., no more than about 50 cm, no more than about 40 cm, no more than about 30 cm, no more than about 20 cm, no more than about 10 cm, or no more than about 8 cm). Generally, the length of the coils, in total, is selected in part to prevent the amount of force used to push the coil assembly from becoming too large.
[0030] The coils may differ in the diameter of the wire from which they are formed. For example, the coils may be formed of wire, e.g., platinum, platinum/tungsten alloy or stainless steel wire, having a diameter of between about 0.001 inch to about 0.005 inch in diameter. One coil may be formed of wire having a diameter of between about 0.001 inch to about 0.0025 inch in diameter, while another coil may be between about 0.003 inch to about 0.005 inch in diameter. The difference in wire diameter can result in a difference in the outer diameter of the first coil and second coil (taken in their primary shapes), given a constant inner diameter of the first and second coils. For example, the outer diameter of one of the first coil and second coil may be between about 0.013 inch to about 0.015 inch and the other of the first coil and second coil may be between about 0.010 inch to about 0.012 inch while sharing a constant inner diameter.
[0031] The outer diameter of the coils may differ regardless of the inner diameter of the coils. The outer diameter of a coil refers to the outer diameter of the coil when in its secondary configuration. In certain embodiments, the outer diameter of the coils can be no more than about 14 mm (e.g., no more than about 12 mm, no more than about 10 mm, no more than about 8 mm, no more than about 6 mm, no more than about 4 mm, or no more than about 2 mm) and/or can be no less than about 1 mm (e.g., no less than about 2 mm, no less than about 4 mm, no less than about 6 mm, no less than about 8 mm, no less
Il than about 10 mm, or no less than about 12 mm). In some embodiments, the outer diameter of the embolic coils can be from about 1 mm to about 14 mm (e.g., from about 2 mm to about 12 mm, from about 4 mm and to about 10 mm, or from about 6 mm and to about 8 mm). In some embodiments, one embolic coil can have an outer diameter no more than about 6 mm (e.g., no more than about 5 mm, no more than about 4 mm, no more than about 3 mm, or no more than about 2 mm) while another embolic coil can have an outer diameter of not less than about 8 mm (e.g., not less than about 10 mm or not less than about 12 mm).
[0032] The stiffness of the coils may be varied. It will be recognized that certain other parameters will affect the stiffness of the coils, for example, the composition and the diameter of the wire from which the coil is formed. The diameter of a mandrel around which the coil is formed (in other words, the inner diameter of the coil) may affect the stiffness. Also, additional treatment of the coil once formed can affect the stiffness. For example, subjecting a coil to heat and then cooling the coil may result in stiffening of the coil. Coil stiffness may vary between about 0.001 lbf and about 0.004 lbf. Coil stiffness can be measured by measuring the force required to compress the outer coil 5% of the main secondary coil diameter. For example, a dynamic testing machine, such as is available from Instron Corp., can be utilized to test coil stiffness. A main outer diameter of a secondary coil is removed from the secondary coil and placed in the gripping mechanism of the testing machine such that only half of the diameter (a semi-circle shape) is exposed. The sample is placed directly below an anvil-like fixture that compresses down on the surface of the outer diameter. The force required to compress the sample by 5% of the overall main outer diameter is measured.
[0033] In some embodiments, some or all of the embolic coils may include fibers. Exemplary fiber materials include polyethylene terephthalate (e.g., Dacron®), nylon, collagen and/or cotton fibers, which may promote thrombosis by providing a substrate for clot formation. The degree of fiber coverage may be varied. For example, some of the embolic coils may have fibers while others do not. In some embodiments, the embolic coils may each have fibers but have different amounts of fibers for a given length of coil. The fibers may be, for example, of the same or different length (generally between about 0.5 mm to about 5 mm), stiffness, and/or diameter. The spacing between fiber bundles and the fiber densities (i.e. number of fiber filaments per fiber bundle) are additional factors capable of variation; one coil can have bundles having greater numbers of fibers than a different coil but have the bundles spaced farther apart, resulting in the same number of fibers per length of coil but a different distribution of fiber coverage on each coil.
[0034] While embodiments that contain two embolic coils have been described, the embolic coil delivery systems can include more than two embolic coils (e.g., three or more, four or more, five or more, or six or more embolic coils). In such embodiments, at least two of the embolic coils differ from each other in at least one coil parameter. In certain embodiments, three or more, four or more, five or more, or six or more embolic coils can differ from each other in at least one coil parameter; further, the coil parameters that differ may be the same coil parameter or may be two or more different coil parameters (e.g., three or more, four or more, five or more, or six or more different coil parameters).
[0035] The embolic coils generally include at least one engaging member for engaging with an adjacent embolic coil, and may optionally include two engaging members for engaging with adjacent embolic coils or pusher wires one either side of the embolic coil. The engaging members generally are configured such that one member reversibly accepts a portion of a corresponding member. Configurations include an engaging member having an open receiving slot generally perpendicular to the longitudinal axis of the coil and corresponding engaging member having a hook adapted to enter and exit an open receiving slot generally perpendicular to the longitudinal axis of the coil, and also include engaging members having an outer portion of a generally cylindrical shape, a middle portion adapted to accept a generally cylindrical outer portion of an adjacent corresponding engaging member, and an inner portion adapted for attaching to the coil (where "outer" refers to the portion of the engaging member distant from the coil to which it is attached and "inner" refers to the portion nearest the coil). The engaging member of one end of a coil may be, but need not be, the same as the engaging member at a different end of the coil, where the coil has two engaging members. Each coil and each engaging member may further include a channel or lumen extending longitudinally, with a control wire extending through the channels to further engage the coils.
[0036] Examples of engaging member embodiments are illustrated in FIGS 4-6. FIGS. 4A and 4B show side and perspective views, respectively, of an embodiment of an engaging member 160. Engaging member 160 is generally cylindrical in shape with a surface 162 which may be cut or milled away to allow the surface to mesh with receiving area 164 on an adjacent engaging member. Connecting end 166 is adapted to be connected to an embolic coil or pusher wire, and may be any suitable shape, e.g., cylindrical. Vertical mating surface 168 is adapted to meet a similar vertical mating face on an adjacent engaging member to allow one engaging member to pull the other when the first engaging member is pulled, while end surface 170 pushes against mating surface 167 when the first engaging member is pushed. FIG. 4C shows a pair of engaging members as described in FIGS. 4A and 4B when engaged, in this case engaging a pusher wire 178 and an embolic coil 180. FIGS. 5 A, 5B and 5C show an interlocking member 172 having an end surface 174 that is ramped. This design can, for example, permit assembly ease in placing the coils into a catheter or introducer sheath.
[0037] In certain embodiments, the engaging members of adjacent embolic coils that are engaged with one another have different configurations from each other. For example, as shown in FIG. 6, each of the pair of engaging members has a differing configuration. A coil 300 has an engaging member 305 which has a slot 310 located thereon. Slot 310 is configured to receive a hook 322 of an engaging member 320, located at an end of coil 400. [0038] In some embodiments, an embolic coil assembly may also include a control wire. The control wire can permit the coils to remain engaged until the control wire is removed and the coil is not constrained by a catheter or introducer sleeve. For example, FIGS. 7A and 7B show an embolic coil assembly 130 in which a coil 128 is engaged with a pusher wire 130 by engaging members 132 in combination with a control wire 106. Each engaging member 132 includes a ramped face 136 with a slot 138 and a longitudinally-extending passageway 140 for receiving control wire 106. Control wire 106 extends through lumens 131 and 133 in the pusher wire 130 and in coil 128, respectively. Engaging members 132 cannot disengage, even when unconstrained by a sleeve, until control wire 106 is pulled out of opening 141 of channel 140. When engaging members 132 are not constrained by a sleeve and control wire 106 has been pulled out of opening 141 of channel 140, the coil 120 will disengage from the pusher wire 130. Such a control wire may be incorporated into any of the other engaging member embodiments.
[0039] FIG. 8 illustrates an embolic coil assembly delivery system in which an embolic coil assembly 202 is contained in an introducer sleeve 204 which is separate from catheter 210. Optionally, the introducer sleeve 204 includes a locking portion 206, e.g., a portion of the introducer sleeve that has been twisted under heat to deform and grip the pusher wire and/or coil assembly, to lock a pusher wire 224 and/or coil assembly 202 in sleeve 204. This may prevent the coil assembly from moving longitudinally in the sleeve and possibly out of the sleeve before such is desired. Such a locking portion can be unlocked, e.g., by untwisting the sheath, to allow the pusher wire/coil assembly to move freely.
[0040] Generally, the catheter 210 is first inserted into a body lumen of a subject, for example, through an incision into the femoral artery, and moved through the body until its distal end is at a target location, for example, the opening of an aneurysm. Once in place, a distal tip 206 of sleeve 204 is placed into a hub 216 attached to a proximal end 212 of the catheter and the embolic coil assembly is pushed by means of pusher wire 224 into catheter 210 and to the distal end of the catheter for delivery to the target site. The pusher wire is then used to push the embolic coil assembly out of the distal tip of the catheter such that individual coils disengage from the assembly and deploy into the target area. Alternatively, the pusher wire may be used to hold the coil assembly in place while the catheter is retracted, thus permitting self-disengagement of individual coils. Where a control wire is included, it may be retracted either before or after pushing the coils out of the catheter or retracting the catheter.
[0041 ] FIGS . 9 A-C illustrate an embodiment of a method for treatment of an aneurysm. A catheter 510 is inserted into the body and guided through a lumen 502 in a vessel 500 to an opening 506 in an aneurysm 504. An embolic coil assembly 514 is inserted into the catheter for deployment into the aneurysm. Embolic coil assembly 514 includes a long coil 536 with an engaging member 522 at a proximal end 540 and two shorter coils 516 and 526, each having engaging members 522 at each end. The coils are selected to accomplish particular tasks with respect to treating the aneurysm. For example, long coil 536 is selected of a sufficient length and secondary shape to frame the embolism to add strength and prevent the aneurysm from rupturing, to begin sealing off the opening 506, and to provide a framework to which shorter coils 516, 526 can attach themselves. Shorter coils 516, 526 have a secondary shape in the form of a J to enable each to be hooked onto this framework and are sufficiently flexible to enable them to pack together densely to fill the voids in the aneurysm. In certain embodiments, the J- shaped coils will themselves be long (e.g., from about 15 mm to about 30 mm) as well as soft and flexible. This can enable a physician to custom fill vessels or aneurysms as desired to achieve a desired density of packing.
[0042] A pusher wire 546 with an engaging member 522 at its distal end 548 is engaged to coil 526. The pusher wire is used to push embolic coil assembly 514 to the distal end 511 of catheter 510 so that the long coil 536 extends partially out of the catheter. The long coil 536 begins to assume its secondary shape as it exits the catheter. At this point, should repositioning be desired, the embolic coil assembly 514 can be retracted into the catheter by pulling back on the pusher wire 546.
[0043] Once in the proper position, as illustrated in FIG. 9B, the embolic coil assembly 514 is pushed sufficiently far distally that the long coil 536 passes entirely out of catheter 510, disengages and assumes its secondary basket shape and frames the aneurysm. At this point, the catheter 510 can be left in position and the remaining coils 516, 526 can be deployed. As seen in FIG. 9C, embolic coils 516 and 526 have a secondary shape in the form of a J to hook onto the long coil 536 and extend into and fill voids in the aneurysm.
The pusher wire 546 need not be withdrawn to permit insertion of the additional coils. This may provide for shorter times of treatment and/or less movement of materials through the catheter, given the lack of a requirement for removing the pusher wire, inserting a J-shaped coil, reinserting the pusher wire and pushing the coil to the distal tip of the catheter, and may lead to superior results.
[0044] FIGS. lOA-C show the occlusion of a vessel 600, with a long coil 636 having a helical secondary shape being first deployed (FIG. 1OA, 10B), followed by a first coil 616 having a secondary shape in the form of a C that can, for example, hook itself into the helical coil 636, and followed by second coil 626 having a secondary shape in the form of a J such that, for example, the hooked portion of the J shape can attach itself to the helical coil and the straight portion can extend into the opening to occlude the vessel 600. Additional coils could be added to the embolic coil assembly, such as coils having as secondary shapes diamonds, vortexes or the like to better occlude the central part of the vessel and interweave themselves with the helical coil.
[0045] While certain embodiments have been described, others are possible.
[0046] As an example, some or all of the embolic coils in the embolic coil assembly may have secondary shapes other than those disclosed above. For example, other suitable secondary shapes, and methods for creating embolic coils having such shapes, are discussed in U.S. Patents 4,994,069, 6,231,586, 6,322,576 and 6,635,069, each of which is hereby incorporated by reference.
[0047] As another example, one or more of the embolic coils may include a coating, e.g., a polymer coating, for example, a lubricous coating, that may reduce friction between the coil and the catheter and allow for easier pushing of the coil.
[0048] As an additional example, one or more coils may further include a therapeutic substance, e.g., a drug, for delivery to the target site along with the coil.
[0049] As a further example, the embolic coils may differ in more than one coil parameter, for example, two, three, four, five or more coil parameters may be different.
[0050] As another example, more than two of the embolic coils may differ in one or more coil parameters, for example, three, four, five, or more coils, even each of the coils, may differ from each other in one or more coil parameters.
[0051 ] At least one of the embolic coils may be made in whole or in part of helical wire.
[0052] At least one of the coils may be made in whole or in part of braided wire.
[0053] At least one of the coils may include a radiopaque marker, which may consist of or be a part of the engaging member.
[0054] At least one of the embolic coils may be formed of a polymer, e.g., a biocompatible polymer. Exemplary polymers include polyethylene, polyurethane, and polypropylene.
[0055] Moreover, while embodiments of the engaging members have been described as being generally cylindrical in cross-sectional shape, the engaging members may have other configurations, for example, pentagonal or hexagonal. Also, the engaging members may have different engaging configurations than those disclosed above. Other suitable engaging members are described in U.S. Patents 5,250, 071, 5,304,195, 5,800,453, 5,800,455, 5,891,130, 5,925,059, 6,099,546, RE37,117 E5 and in WO 94/06503, each of which is hereby incorporated by reference.
[0056] Further, in some embodiments, a saline flush can be used to deliver an embolic coil from the sleeve rather than, or in addition to, the pusher wire.
[0057] Still further, in some embodiments, embolic coils can be used in conjunction with other embolic devices. Other embolic devices include, for example, embolic particles such as those described in U.S. Published Patent Application No. 2003/0185896 Al, published on October 2, 2003, and in U.S. Published Patent Application No. US 2004/0096662 Al, published on May 20, 2004, each of which are hereby incorporated by reference. Other embolic devices also include, for example, embolic gels such as described, for example, in U.S.
Patent Application No. 10/927,868, filed on August 27, 2004, and entitled "Embolization", which is hereby incorporated by reference.
[0058] In general, embolic coils may be used to treat a variety of conditions. For example, embolic coils may be used generally to treat neurological and/or peripheral conditions such as to occlude a vessel or to treat an aneurysm, an arteriovenous malformation (AVM), or a traumatic fistula. Embolic coils can be used to embolize a tumor, for example, a liver tumor. Embolic coils can be used in transarterial chemoembolization (TACE).
[0059] Other embodiments are in the claims.

Claims

WHAT IS CLAIMED IS:
1. A coil assembly, comprising: a first embolic coil having an engaging member; and a second embolic coil having an engaging member engaged with the engaging member of the first embolic coil, wherein the first embolic coil differs from the second embolic coil in at least one coil parameter.
2. The coil assembly of claim 1 , wherein the coil parameter is selected from the group consisting of length, inner diameter, outer diameter, stiffness, secondary shape, and degree of fiber coverage.
3. The coil assembly of claim 1, further comprising a sleeve at least partially surrounding the first and second embolic coils, wherein the engaging member of the first embolic coil remains engaged with the engaging member of the second embolic coil when constrained by the sleeve, and the engaging member of the first embolic coil is capable of disengaging from the engaging member of the second embolic coil when unconstrained by the sleeve.
4. The coil assembly of claim 1, wherein movement of the second embolic coil in a proximal or distal direction results in movement of the first embolic coil in the same direction.
5. The coil assembly of claim 1 , further comprising a pusher wire including an engaging member at a distal end, wherein the second embolic coil further comprises an engaging member at its proximal end capable of engaging with the engaging member located at the distal end of the pusher wire.
6. The coil assembly of claim 1 , further comprising a third embolic coil having an engaging member at its proximal end, wherein the first embolic coil has an engaging member at its distal end engaged to the engaging member at the proximal end of the third embolic coil.
7. The coil assembly of claim 6, further comprising a sleeve at least partially surrounding the first and third embolic coils, wherein the engaging member of the first embolic coil remains engaged with the engaging member of the third embolic coil when constrained by the sleeve, and the engaging member of the first embolic coil is capable of disengaging from the engaging member of the third embolic coil when unconstrained by the sleeve.
8. The coil assembly of claim 1, wherein the first and second embolic coils differ in length.
9. The coil assembly of claim 8, wherein the first embolic coil is at least 50 cm long and the second embolic coil is no more than 10 cm long.
10. The coil assembly of claim 1 , wherein the first and second embolic coils differ in secondary shape.
11. The coil assembly of claim 10, wherein the secondary shapes of the first and second embolic coils are each independently selected from the group consisting of helical, diamond, cone-shaped, random, basket-shaped, straight, and
J-shaped.
12. The coil assembly of claim 10, wherein the secondary shape of the first embolic coil is a basket shape and the secondary shape of the second embolic coil is a J-shape.
13. The coil assembly of claim 10, wherein the secondary shape of the first embolic coil is a helical shape and the secondary shape of the second embolic coil is a diamond.
14. The coil assembly of claim 1, wherein the first embolic coil and the second embolic coil differ in stiffness.
15. The coil assembly of claim 1, wherein the first embolic coil and the second embolic coil differ in outer diameter.
16. The coil assembly of claim 15, wherein the outer diameter of one of the first embolic coil and second embolic coil is at least about 0.013 inch and the other of the first embolic coil and second embolic coil is at most about 0.012 inch.
17. The coil assembly of claim 1, further comprising a catheter and a pusher wire, the catheter containing the first embolic coil, the second embolic coil and the pusher wire, the pusher wire being adapted to push the first embolic coil and second embolic coil from a proximal end of the catheter to a distal end of the catheter.
18. The coil assembly of claim 17, further comprising an introducer sheath capable of containing the first and second embolic coils in an engaged state, the introducer sheath adapted to abut the proximal end of the catheter to permit passage of the fist and second embolic coils from the introducer sheath to the catheter without the first and second embolic coils disengaging.
19. A coil assembly, comprising: three or more embolic coils, wherein each of the embolic coils has an engaging member at each end that is adjacent to another embolic coil, each engaging member is engaged with an engaging member of an adjacent embolic coil, and at least one embolic coil differs from at least one other embolic coil in at least one coil parameter.
20. The coil assembly of claim 19, wherein the coil parameter is selected from the group consisting of length, inner diameter, outer diameter, stiffness, secondary shape, and degree of fiber coverage.
21. The coil assembly of claim 20, further comprising a sleeve at least partially surrounding the embolic coils, wherein the engaging members of adjacent embolic coils are engaged when constrained by the sleeve, and the engaging members of adjacent embolic coils are capable of disengaging from each other when unconstrained by the sleeve.
22. A method, comprising: inserting a coil assembly into a body lumen of a subject, the coil assembly comprising: a first embolic coil having an engaging member; and a second embolic coil having an engaging member engaged with the engaging member of the first embolic coil,
1 wherein the first embolic coil differs from the second embolic coil in at least one coil parameter.
23. The method of claim 22, wherein the coil parameter is selected from the group consisting of length, inner diameter, outer diameter, stiffness, secondary shape, and degree of fiber coverage.
24. The method of claim 22, further comprising: introducing a distal end of a catheter into the body lumen of the subject; inserting into a proximal end of the catheter the coil assembly; deploying the first embolic coil by pushing the coil assembly towards the distal end of the catheter sufficiently far so that the first embolic coil is pushed fully out of the catheter and disengages from the second embolic coil; and deploying the second embolic coil by pushing the coil assembly towards the distal end of the catheter sufficiently far so that the second embolic coil is pushed fully out of the catheter.
25. The method of claim 24, wherein the coil assembly further comprises additional embolic coils, and the method further comprises deploying at least one of the additional embolic coils by pushing the coil assembly towards the distal end of the catheter sufficiently far so that the at least one of the additional embolic coils are pushed fully out of the catheter.
26. The method of claim 22, wherein the coil assembly is pushed by a pusher wire.
27. The method of claim 26, wherein the pusher wire comprises at a distal end an engaging member that is engaged with an engaging member of a proximal- most coil in the coil assembly.
28. The method of claim 27, further comprising the step of at least partially retracting the coil assembly into the catheter.
29. The method of claim 22, further comprising: determining appropriate coil parameters for treatment of a vascular defect; and selecting first and second embolic coils that have the appropriate coil parameters.
30. The method of claim 29, wherein the vascular defect is an aneurism, and the method further comprises selecting a first coil of sufficient length, stiffness and secondary shape to form a basket when deployed in the aneurism, and selecting a second coil of sufficient length, stiffness and secondary shape to fill at least a portion of the basket when deployed in the aneurism.
31. The method of claim 29, wherein the vascular defect is a vessel that is desired to be occluded, and the method further comprises selecting a first coil of sufficient length, stiffness and secondary shape to form a helical shape when deployed in the vessel and selecting a second coil of sufficient length, stiffness and secondary shape to form a diamond shape within the helical shape of the first coil when deployed in the vessel.
32. The method of claim 22, wherein each coil and each engaging member further includes a longitudinally extending channel, the coil assembly further comprises a control wire extending through the channels, and the method further
5 comprises retracting the control wire to allow the engaging members to disengage.
33. The method of claim 32, wherein the first and second embolic coils are contained in a catheter, and the method further comprises retracting the control wire and then pushing the coil assembly distally sufficiently far so that the first o embolic coil is pushed fully out of the catheter.
34. The method of claim 32, wherein the first and second embolic coils are contained in a catheter, and the method further comprises pushing the coil assembly distally sufficiently far so that the first embolic coil is pushed fully out 5 of the catheter and then retracting the control wire.
35. A method of deploying embolic coils at a site within a subject, the method comprising: disposing a distal end of a catheter at the site; 0 disposing a coil assembly comprising at least two embolic coils at the distal end of the catheter; and deploying at least two embolic coils in the coil assembly out of the catheter to the site, wherein at least one embolic coil differs from at least another embolic 5 coil in at least one coil parameter.
36. The method of claim 35, wherein the coil parameter is selected from the group consisting of length, inner diameter, outer diameter, stiffness, secondary shape, and degree of fiber coverage. 0
37. The method of claim 35, wherein each coil in the coil assembly is initially engaged with a coil adjacent to it, and the method further comprises disengaging each coil from the coil adjacent to it.
PCT/US2006/038811 2005-10-12 2006-10-03 Coil assemblies, components and methods WO2007047111A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/248,033 US8007509B2 (en) 2005-10-12 2005-10-12 Coil assemblies, components and methods
US11/248,033 2005-10-12

Publications (1)

Publication Number Publication Date
WO2007047111A1 true WO2007047111A1 (en) 2007-04-26

Family

ID=37564308

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/038811 WO2007047111A1 (en) 2005-10-12 2006-10-03 Coil assemblies, components and methods

Country Status (2)

Country Link
US (1) US8007509B2 (en)
WO (1) WO2007047111A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017039672A1 (en) * 2015-09-03 2017-03-09 Elenza, Inc. Rechargeable intraocular implant
WO2018195236A1 (en) * 2017-04-19 2018-10-25 Boston Scientific Scimed, Inc. Variable length vascular occlusion system
US10874402B2 (en) 2017-10-10 2020-12-29 Boston Scientific Scimed, Inc. Detachable RF energized occlusive device
US11000287B2 (en) 2017-08-15 2021-05-11 Boston Scientific Scimed, Inc. Occlusive medical device system
US11154412B2 (en) 2018-02-01 2021-10-26 Boston Scientific Scimed, Inc. Medical device release system
US11191927B2 (en) 2017-07-31 2021-12-07 Boston Scientific Scimed, Inc. Dilator with engagement region
US11284902B2 (en) 2018-02-01 2022-03-29 Boston Scientific Scimed, Inc. Method of making a vascular occlusion device
US11672946B2 (en) 2019-09-24 2023-06-13 Boston Scientific Scimed, Inc. Protection and actuation mechanism for controlled release of implantable embolic devices

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7094369B2 (en) * 2002-03-29 2006-08-22 Scimed Life Systems, Inc. Processes for manufacturing polymeric microspheres
US7879064B2 (en) 2004-09-22 2011-02-01 Micro Therapeutics, Inc. Medical implant
US9463426B2 (en) 2005-06-24 2016-10-11 Boston Scientific Scimed, Inc. Methods and systems for coating particles
EP1931265B1 (en) * 2005-09-30 2011-12-07 Cook Medical Technologies LLC Coated vaso-occlusion device
US8152839B2 (en) 2005-12-19 2012-04-10 Boston Scientific Scimed, Inc. Embolic coils
US8101197B2 (en) 2005-12-19 2012-01-24 Stryker Corporation Forming coils
US7947368B2 (en) 2005-12-21 2011-05-24 Boston Scientific Scimed, Inc. Block copolymer particles
US8777979B2 (en) 2006-04-17 2014-07-15 Covidien Lp System and method for mechanically positioning intravascular implants
CA2649702C (en) 2006-04-17 2014-12-09 Microtherapeutics, Inc. System and method for mechanically positioning intravascular implants
US20070299461A1 (en) * 2006-06-21 2007-12-27 Boston Scientific Scimed, Inc. Embolic coils and related components, systems, and methods
AU2007285800A1 (en) * 2006-08-17 2008-02-21 Nfocus Neuromedical, Inc. Isolation devices for the treatment of aneurysms
US8414927B2 (en) 2006-11-03 2013-04-09 Boston Scientific Scimed, Inc. Cross-linked polymer particles
US20080208214A1 (en) * 2007-02-26 2008-08-28 Olympus Medical Systems Corp. Applicator and tissue fastening method through natural orifice
KR20100015521A (en) * 2007-03-13 2010-02-12 마이크로 테라퓨틱스 인코포레이티드 An implant, a mandrel, and a method of forming an implant
JP2010524631A (en) * 2007-04-23 2010-07-22 インターヴェンショナル アンド サージカル イノヴェイションズ リミテッド ライアビリティ カンパニー Guidewire with adjustable stiffness
US9387308B2 (en) 2007-04-23 2016-07-12 Cardioguidance Biomedical, Llc Guidewire with adjustable stiffness
US8328841B2 (en) * 2007-05-22 2012-12-11 Cook Medical Technologies Llc Embolization coil delivery systems and methods
US7901704B2 (en) * 2007-08-21 2011-03-08 Boston Scientific Scimed, Inc. Embolization
US8956475B2 (en) 2007-12-11 2015-02-17 Howard Riina Method and apparatus for restricting flow through an opening in the side wall of a body lumen, and/or for reinforcing a weakness in the side wall of a body lumen, while still maintaining substantially normal flow through the body lumen
CA2720206C (en) * 2008-04-04 2016-10-04 Curaseal, Inc. Implantable fistula closure device
EP2633823B1 (en) 2008-04-21 2016-06-01 Covidien LP Braid-ball embolic devices and delivery systems
US9675482B2 (en) 2008-05-13 2017-06-13 Covidien Lp Braid implant delivery systems
EP2330985A4 (en) 2008-09-04 2015-11-18 Curaseal Inc Inflatable devices for enteric fistula treatment
WO2010085344A1 (en) 2009-01-22 2010-07-29 Cornell University Method and apparatus for restricting flow through the wall of a lumen
CA2785621C (en) * 2009-04-02 2015-12-22 The Regents Of The University Of Colorado, A Body Corporate Vascular occlusion devices
WO2010134914A1 (en) * 2009-05-20 2010-11-25 University Of Miami Spherical helix embolic coils for the treatment of cerebral aneurysms
BR112012009118A8 (en) 2009-10-21 2017-10-10 Koninklijke Philips Electronics Nv METHOD OF INTERACTIVE DETERMINATION OF WINDING PARAMETERS TO FILL A LUMEN WITH AT LEAST ONE COIL, DEVICE CONFIGURED TO PERFORM THE METHOD AND COMPUTER PROGRAM PRODUCT
US9814562B2 (en) 2009-11-09 2017-11-14 Covidien Lp Interference-relief type delivery detachment systems
US8906057B2 (en) * 2010-01-04 2014-12-09 Aneuclose Llc Aneurysm embolization by rotational accumulation of mass
US8998947B2 (en) 2010-09-10 2015-04-07 Medina Medical, Inc. Devices and methods for the treatment of vascular defects
EP3354210B1 (en) 2010-09-10 2022-10-26 Covidien LP Devices for the treatment of vascular defects
CN103874466B (en) 2011-06-16 2016-10-05 库拉希尔公司 Device and correlation technique for fistula treatment
US9131941B2 (en) 2011-06-17 2015-09-15 Curaseal Inc. Fistula treatment devices and methods
US9498226B2 (en) * 2011-09-16 2016-11-22 Cook Medical Technologies, LLC Embolic coil delivery system
US8795313B2 (en) 2011-09-29 2014-08-05 Covidien Lp Device detachment systems with indicators
US8945171B2 (en) 2011-09-29 2015-02-03 Covidien Lp Delivery system for implantable devices
WO2014160320A2 (en) 2013-03-13 2014-10-02 Endoshape Inc. Continuous embolic coil and methods and devices for delivery of the same
WO2013055703A1 (en) * 2011-10-07 2013-04-18 Cornell University Method and apparatus for restricting flow through an opening in a body lumen while maintaining normal flow
US9579104B2 (en) 2011-11-30 2017-02-28 Covidien Lp Positioning and detaching implants
EP2804542B1 (en) 2012-01-17 2017-03-01 Endoshape, Inc. Occlusion device for a vascular or biological lumen
US9011480B2 (en) 2012-01-20 2015-04-21 Covidien Lp Aneurysm treatment coils
WO2013112944A1 (en) * 2012-01-26 2013-08-01 Endoshape, Inc. Systems, devices, and methods for delivering a lumen occlusion device using distal and/or proximal control
US9687245B2 (en) 2012-03-23 2017-06-27 Covidien Lp Occlusive devices and methods of use
EP2846707A4 (en) * 2012-05-04 2016-11-30 Interventco Llc Device and method for filling of aneurysm or body cavity
US10159489B2 (en) 2012-07-30 2018-12-25 Cook Medical Technologies Llc Systems and methods for delivering multiple embolization coils
KR102309795B1 (en) 2012-11-13 2021-10-08 코비디엔 엘피 Occlusive devices
GB2509952B (en) * 2013-01-18 2015-01-28 Cook Medical Technologies Llc Medical device loading and carrier tool
US9119948B2 (en) 2013-02-20 2015-09-01 Covidien Lp Occlusive implants for hollow anatomical structures, delivery systems, and related methods
WO2014164496A1 (en) * 2013-03-11 2014-10-09 Ferry Steven J Flat wound detachable embolization coil
US10172734B2 (en) * 2013-03-13 2019-01-08 DePuy Synthes Products, Inc. Capture tube mechanism for delivering and releasing a stent
US9763667B2 (en) * 2013-03-14 2017-09-19 Cook Medical Technologies Llc Embolization coil with barbed fiber
EP2967576B1 (en) 2013-03-15 2023-02-15 Covidien LP Delivery and detachment mechanisms for vascular implants
FR3008304B1 (en) * 2013-07-15 2016-04-01 Balt Extrusion ENDOPROTHESIS FOR THE TREATMENT IN PARTICULAR AN ANEURYSM
WO2015095806A2 (en) 2013-12-20 2015-06-25 Microvention, Inc. Device delivery system
US9675361B2 (en) 2014-02-28 2017-06-13 Cook Medical Technologies Llc Coil occlusion device
US9713475B2 (en) 2014-04-18 2017-07-25 Covidien Lp Embolic medical devices
US10595875B2 (en) 2014-12-31 2020-03-24 Endostream Medical Ltd. Device for restricting blood flow to aneurysms
EP4275623A3 (en) * 2015-02-05 2024-01-24 Boston Scientific Scimed, Inc. Detachable implantable devices
US9375333B1 (en) * 2015-03-06 2016-06-28 Covidien Lp Implantable device detachment systems and associated devices and methods
EP4299019A3 (en) * 2015-04-01 2024-03-06 Boston Scientific Scimed, Inc. Systems for delivery of gel embolics
US10232154B2 (en) 2015-07-28 2019-03-19 Boston Scientific Scimed, Inc. Implantable medical devices and related methods of use
US10966728B2 (en) 2016-06-21 2021-04-06 Endostream Medical Ltd. Medical device for treating vascular malformations
US10478195B2 (en) 2016-08-04 2019-11-19 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
WO2018053314A1 (en) 2016-09-16 2018-03-22 Greg Mirigian Occlusive implants with fiber-based release structures
HUE061376T2 (en) * 2016-12-16 2023-06-28 Edwards Lifesciences Corp Deployment systems and tools for delivering an anchoring device for a prosthetic valve
JP2019024587A (en) * 2017-07-25 2019-02-21 千貴 寺嶋 Vascular marker for radiation therapy, staying support device of vascular marker, radiation irradiation control device and radiation irradiation control program
WO2019022168A1 (en) 2017-07-25 2019-01-31 千貴 寺嶋 Vascular marker for radiotherapy, radiotherapy assistance method, radiation irradiation control device, and vascular marker indwelling assistance device
US10675036B2 (en) 2017-08-22 2020-06-09 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
KR102063535B1 (en) * 2018-05-29 2020-01-08 인제대학교 산학협력단 Coil with adjustable length and how to detach-length the coil
CN111388045A (en) 2018-12-17 2020-07-10 柯惠有限合伙公司 Occlusion device
WO2020148768A1 (en) 2019-01-17 2020-07-23 Endostream Medical Ltd. Vascular-malformation implant system
US11399840B2 (en) 2019-08-13 2022-08-02 Covidien Lp Implantable embolization device
US11504816B2 (en) 2019-11-04 2022-11-22 Covidien Lp Systems and methods for treating aneurysms
US11931041B2 (en) 2020-05-12 2024-03-19 Covidien Lp Devices, systems, and methods for the treatment of vascular defects

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994069A (en) 1988-11-02 1991-02-19 Target Therapeutics Vaso-occlusion coil and method
US5250071A (en) 1992-09-22 1993-10-05 Target Therapeutics, Inc. Detachable embolic coil assembly using interlocking clasps and method of use
WO1994006503A1 (en) * 1992-09-22 1994-03-31 Target Therapeutics, Inc. Detachable embolic coil assembly
US5304195A (en) 1991-12-12 1994-04-19 Target Therapeutics, Inc. Detachable pusher-vasoocclusive coil assembly with interlocking coupling
US5800453A (en) 1993-04-19 1998-09-01 Target Therapeutics, Inc. Detachable embolic coil assembly using interlocking hooks and slots
WO1999042038A1 (en) * 1998-02-18 1999-08-26 Boston Scientific Limited Vaso-occlusive member assembly with multiple detaching points
WO2000053105A1 (en) * 1999-03-09 2000-09-14 Micrus Corporation Shape memory segmented detachable coil
US6159206A (en) * 1997-10-30 2000-12-12 Kaneka Medix Corporation Medical implement for depositing implanted device and method of depositing implanted device
US6231586B1 (en) 1995-06-06 2001-05-15 Target Therapeutics, Inc. Three dimensional in-filling vaso-occlusive coils
US6322576B1 (en) 1997-08-29 2001-11-27 Target Therapeutics, Inc. Stable coil designs
US6635069B1 (en) 2000-10-18 2003-10-21 Scimed Life Systems, Inc. Non-overlapping spherical three-dimensional coil

Family Cites Families (358)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE233303C (en) 1911-04-05
US2609347A (en) 1948-05-27 1952-09-02 Wilson Christopher Lumley Method of making expanded polyvinyl alcohol-formaldehyde reaction product and product resulting therefrom
JPS4820019B1 (en) 1969-06-05 1973-06-18
US3737398A (en) 1969-11-13 1973-06-05 D Yamaguchi Method of making a polyvinyl acetal sponge buff
US3921632A (en) 1974-08-16 1975-11-25 Frank M Bardani Implant device
CS179075B1 (en) 1974-11-26 1977-10-31 Stoy Vladimir Mode of manufacture of spherical particles from polymer
US4076640A (en) * 1975-02-24 1978-02-28 Xerox Corporation Preparation of spheroidized particles
US3957933A (en) 1975-03-05 1976-05-18 General Atomic Company Apparatus for producing microspherical particles and method for operating such apparatus
JPS51135958A (en) 1975-05-20 1976-11-25 Fuji Photo Film Co Ltd Method of making fine powder polymer having pores
US4025686A (en) 1975-06-26 1977-05-24 Owens-Corning Fiberglas Corporation Molded composite article and method for making the article
US4034759A (en) 1975-08-27 1977-07-12 Xomed, Inc. Moisture-expandable prosthesis
US4098728A (en) 1976-01-02 1978-07-04 Solomon Rosenblatt Medical surgical sponge and method of making same
US4055377A (en) 1976-08-03 1977-10-25 Minnesota Mining And Manufacturing Company Magnetically orientable retroreflectorization particles
GB1591924A (en) * 1976-10-25 1981-07-01 Berger Jenson & Nicholson Ltd Polymer aggregates
US4159719A (en) 1977-05-09 1979-07-03 Xomed, Inc. Moisture-expandable ear wick
US4900303A (en) * 1978-03-10 1990-02-13 Lemelson Jerome H Dispensing catheter and method
ES478736A1 (en) * 1978-03-23 1979-06-01 Hoechst Ag Polyvinyl alcohol pellets containing a plasticizer, and method for their preparation.
DE2834539A1 (en) 1978-08-07 1980-02-21 Basf Ag MACROPOROUS POLYMERS AS CARRIER MATERIAL FOR THE COVALENT BINDING OF PROTEINS
US4793980A (en) 1978-09-21 1988-12-27 Torobin Leonard B Hollow porous microspheres as substrates and containers for catalyst
US4243794A (en) 1978-10-10 1981-01-06 Minnesota Mining And Manufacturing Company Mixture of rough and spheroidized resin particles
US4198318A (en) * 1978-11-24 1980-04-15 Conoco, Inc. Production of high strength alumina spheres by hydrogelling corresponding slurries
US4268495A (en) 1979-01-08 1981-05-19 Ethicon, Inc. Injectable embolization and occlusion solution
US4246208A (en) * 1979-03-22 1981-01-20 Xerox Corporation Dust-free plasma spheroidization
US4346712A (en) 1979-04-06 1982-08-31 Kuraray Company, Ltd. Releasable balloon catheter
HU184722B (en) * 1980-02-18 1984-10-29 Laszlo Lazar Therapeutically suitable silicone rubber mixture and therapeuticaid
US4271281A (en) 1980-05-29 1981-06-02 American Hoechst Corporation Process for preparing styrenic polymer particles
DE3031737A1 (en) * 1980-08-22 1982-04-01 Bayer Ag, 5090 Leverkusen METHOD FOR PRODUCING PEARL POLYMERISATS OF UNIFORM PARTICLE SIZE
CA1166413A (en) * 1980-10-30 1984-05-01 Edward E. Timm Process and apparatus for preparing uniform size polymer beads
US4657756A (en) * 1980-11-17 1987-04-14 Schering Aktiengesellschaft Microbubble precursors and apparatus for their production and use
US4681119A (en) * 1980-11-17 1987-07-21 Schering Aktiengesellschaft Method of production and use of microbubble precursors
US4442843A (en) * 1980-11-17 1984-04-17 Schering, Ag Microbubble precursors and methods for their production and use
NZ199916A (en) * 1981-03-11 1985-07-12 Unilever Plc Low density polymeric block material for use as carrier for included liquids
US4678814A (en) * 1981-03-30 1987-07-07 California Institute Of Technology Polyacrolein microspheres
US4622362A (en) * 1981-03-30 1986-11-11 California Institute Of Technology Polyacrolein microspheres
US4413070A (en) 1981-03-30 1983-11-01 California Institute Of Technology Polyacrolein microspheres
CA1177811A (en) 1981-04-13 1984-11-13 Theo G. Spek Process for the preparation of silica particles; silica particles with a narrow pore diameter distribution, catalysts made therefrom and use of these catalysts
US4428869A (en) * 1981-08-20 1984-01-31 International Flavors & Fragrances Inc. Cologne consisting of microcapsule suspension
US4456693A (en) * 1982-03-08 1984-06-26 W. R. Grace & Co. Hydrocracking catalyst
US4452773A (en) * 1982-04-05 1984-06-05 Canadian Patents And Development Limited Magnetic iron-dextran microspheres
US4472552A (en) * 1982-09-27 1984-09-18 W. R. Grace & Co. Continuous process for making solid, free-flowing water dispersible PVA-aldehyde reaction product
US4459145A (en) * 1982-09-30 1984-07-10 The United States Of America As Represented By The United States Department Of Energy Fabrication of glass microspheres with conducting surfaces
DE3313946A1 (en) 1983-04-15 1984-10-18 Schering AG, 1000 Berlin und 4709 Bergkamen MICROPARTICLES AND GAS BUBBLES CONTAINING ULTRASONIC CONTRASTING AGENTS
DE3834705A1 (en) 1988-10-07 1990-04-12 Schering Ag ULTRASONIC CONTRASTING AGENTS FROM GAS BUBBLES AND MICROPARTICLES CONTAINING FATTY ACID
DE3313947A1 (en) 1983-04-15 1984-10-18 Schering AG, 1000 Berlin und 4709 Bergkamen MICROPARTICLES AND GAS BUBBLES CONTAINING ULTRASONIC CONTRASTING AGENTS
CA1225585A (en) * 1983-06-30 1987-08-18 Maria T. Litvinova Composition for embolization of blood vessels
US4492720A (en) * 1983-11-15 1985-01-08 Benjamin Mosier Method of preparing microspheres for intravascular delivery
US4573967A (en) * 1983-12-06 1986-03-04 Eli Lilly And Company Vacuum vial infusion system
US4671954A (en) * 1983-12-13 1987-06-09 University Of Florida Microspheres for incorporation of therapeutic substances and methods of preparation thereof
US4551436A (en) * 1984-04-11 1985-11-05 General Electric Company Fabrication of small dense silicon carbide spheres
US4674480A (en) * 1984-05-25 1987-06-23 Lemelson Jerome H Drug compositions and methods of applying same
FR2566384B1 (en) * 1984-06-21 1986-09-05 Saint Gobain Vitrage IMPROVEMENTS IN TECHNIQUES FOR THE PRODUCTION OF GLASS MICROSPHERES
DE3527482A1 (en) 1984-07-31 1986-02-06 Fuji Spinning Co., Ltd., Tokio/Tokyo METHOD FOR PRODUCING GRAINY POROUS CHITOSAN
GB8419708D0 (en) * 1984-08-02 1984-09-05 Shell Int Research Preparation of silica spheres
US4623706A (en) * 1984-08-23 1986-11-18 The Dow Chemical Company Process for preparing uniformly sized polymer particles by suspension polymerization of vibratorily excited monomers in a gaseous or liquid stream
JPS61101242A (en) * 1984-10-22 1986-05-20 Showa Denko Kk Production of coated substance
US4789501A (en) * 1984-11-19 1988-12-06 The Curators Of The University Of Missouri Glass microspheres
US4675113A (en) * 1984-11-28 1987-06-23 University Patents, Inc. Affinity chromatography using dried calcium alginate-magnetite separation media in a magnetically stabilized fluidized bed
DE3568442D1 (en) * 1984-12-06 1989-04-06 Kanegafuchi Chemical Ind A method of preparation of droplets
US5106903A (en) * 1984-12-17 1992-04-21 Lehigh University Preparation of large particle size monodisperse latexes
US4897255A (en) * 1985-01-14 1990-01-30 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
JPH0678460B2 (en) * 1985-05-01 1994-10-05 株式会社バイオマテリアル・ユニバース Porous transparent polyvinyl alcohol gel
JPS61293911A (en) * 1985-06-24 1986-12-24 Teisan Seiyaku Kk Sustained release preparation
US4708718A (en) * 1985-07-02 1987-11-24 Target Therapeutics Hyperthermic treatment of tumors
SE459005B (en) * 1985-07-12 1989-05-29 Aake Rikard Lindahl SET TO MANUFACTURE SPHERICAL POLYMER PARTICLES
USH915H (en) 1985-07-22 1991-05-07 Gibbs Marylu B Controlled macroporous copolymer properties by removal of impurities in the diluent
US4742086A (en) * 1985-11-02 1988-05-03 Lion Corporation Process for manufacturing porous polymer
DE3543348A1 (en) 1985-12-07 1987-06-11 Bayer Ag PEARL-SHAPED CROSS-NETWORKED MIXED POLYMERS WITH EPOXY AND BASIC AMINO GROUPS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE
JPS62169723A (en) * 1986-01-22 1987-07-25 Teisan Seiyaku Kk Sustained release preparation
US4929400A (en) 1986-04-28 1990-05-29 California Institute Of Technology Production of monodisperse, polymeric microspheres
US5262176A (en) 1986-07-03 1993-11-16 Advanced Magnetics, Inc. Synthesis of polysaccharide covered superparamagnetic oxide colloids
JPS6317904A (en) 1986-07-09 1988-01-25 Mitsubishi Chem Ind Ltd Production of crosslinked porous polyvinyl alcohol particle
US4743507A (en) 1986-09-12 1988-05-10 Franses Elias I Nonspherical microparticles and method therefor
US5114421A (en) 1986-09-22 1992-05-19 Polak Robert B Medicament container/dispenser assembly
US4859711A (en) 1986-10-01 1989-08-22 Alcan International Limited Hollow microspheres
CA1287459C (en) 1986-10-01 1991-08-13 Mukesh Jain Process for the preparation of hollow microspheres
US5263992A (en) 1986-10-17 1993-11-23 Bio-Metric Systems, Inc. Biocompatible device with covalently bonded biocompatible agent
EP0265924B2 (en) 1986-10-29 1998-04-22 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Uniform polymer particles
US5292814A (en) * 1987-04-29 1994-03-08 Ernst Bayer Process for the preparation of monodispersed polymer beads
US4795741A (en) * 1987-05-06 1989-01-03 Biomatrix, Inc. Compositions for therapeutic percutaneous embolization and the use thereof
JPH0612993B2 (en) 1987-08-10 1994-02-23 株式会社クラレ Method for producing spherical microbe-immobilized moldings
US4819637A (en) * 1987-09-01 1989-04-11 Interventional Therapeutics Corporation System for artificial vessel embolization and devices for use therewith
JPH0762054B2 (en) 1987-10-13 1995-07-05 倉敷紡績株式会社 Crosslinked polymer particles
US4804366A (en) * 1987-10-29 1989-02-14 Baxter International Inc. Cartridge and adapter for introducing a beneficial agent into an intravenous delivery system
US4850978A (en) 1987-10-29 1989-07-25 Baxter International Inc. Drug delivery cartridge with protective cover
US4981625A (en) * 1988-03-14 1991-01-01 California Institute Of Technology Monodisperse, polymeric microspheres produced by irradiation of slowly thawing frozen drops
FR2634376B1 (en) * 1988-07-21 1992-04-17 Farmalyoc NOVEL SOLID AND POROUS UNIT FORM COMPRISING MICROPARTICLES AND / OR NANOPARTICLES, AS WELL AS ITS PREPARATION
DE68922497T2 (en) 1988-08-24 1995-09-14 Marvin J Slepian ENDOLUMINAL SEAL WITH BISDEGRADABLE POLYMERS.
DE3829938A1 (en) 1988-09-02 1990-03-29 Hermann Hofmann ORGANO-MINERAL DUENGER AND METHOD FOR THE PRODUCTION THEREOF
US4933372A (en) 1988-09-26 1990-06-12 Supelco, Inc. Porous rigid resins and process of preparation
US5047438A (en) 1988-09-26 1991-09-10 Supelco, Inc. Porous rigid resins and process of preparation
US5681576A (en) 1988-11-16 1997-10-28 Mdv Technologies, Inc. Method and composition for post surgical adhesion reduction
DE3841401A1 (en) 1988-12-08 1990-06-13 Martin Lemperle ALLOPLASTIC IMPLANT
US5258028A (en) 1988-12-12 1993-11-02 Ersek Robert A Textured micro implants
US4946899A (en) 1988-12-16 1990-08-07 The University Of Akron Thermoplastic elastomers of isobutylene and process of preparation
GB8900376D0 (en) 1989-01-09 1989-03-08 Nycomed As Iodinated esters
FR2641692A1 (en) * 1989-01-17 1990-07-20 Nippon Zeon Co Plug for closing an opening for a medical application, and device for the closure plug making use thereof
US5091205A (en) * 1989-01-17 1992-02-25 Union Carbide Chemicals & Plastics Technology Corporation Hydrophilic lubricious coatings
US5032117A (en) 1989-01-30 1991-07-16 Motta Louis J Tandem syringe
GB8905934D0 (en) * 1989-03-15 1989-04-26 Dow Europ Sa A process for preparing adsorptive porous resin beads
US5354290A (en) 1989-05-31 1994-10-11 Kimberly-Clark Corporation Porous structure of an absorbent polymer
CA2017570C (en) * 1989-05-31 2000-12-19 James R. Gross Porous structure of an absorbent polymer
US5158573A (en) 1989-06-09 1992-10-27 American Medical Systems, Inc. Injectable polymeric bodies
US5007940A (en) 1989-06-09 1991-04-16 American Medical Systems, Inc. Injectable polymeric bodies
US5116387A (en) 1989-06-09 1992-05-26 American Medical Systems, Inc. Preparation of injectable polymeric bodies
US5190760A (en) * 1989-07-08 1993-03-02 Coopers Animal Health Limited Solid pharmaceutical composition
US5698271A (en) 1989-08-22 1997-12-16 Immunivest Corporation Methods for the manufacture of magnetically responsive particles
US5253991A (en) 1989-11-20 1993-10-19 Sumitomo Cement Co., Ltd. Apparatus for producing spheroidal inorganic particulate material
US5469854A (en) 1989-12-22 1995-11-28 Imarx Pharmaceutical Corp. Methods of preparing gas-filled liposomes
US5542935A (en) 1989-12-22 1996-08-06 Imarx Pharmaceutical Corp. Therapeutic delivery systems related applications
US5580575A (en) 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US5922304A (en) 1989-12-22 1999-07-13 Imarx Pharmaceutical Corp. Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
US5585112A (en) 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US6306427B1 (en) 1989-12-28 2001-10-23 Rhone-Poulenc Nutrition Animale Pellets containing active ingredients protected against degradation in the rumen of ruminants
US5435645A (en) 1989-12-29 1995-07-25 Tecres Spa Process and apparatus for the mixing and direct emplacement of a two-component bone cement
US5122136A (en) * 1990-03-13 1992-06-16 The Regents Of The University Of California Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5354295A (en) 1990-03-13 1994-10-11 Target Therapeutics, Inc. In an endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5147937A (en) 1990-03-22 1992-09-15 Rohm And Haas Company Process for making controlled, uniform-sized particles in the 1 to 50 micrometer range
US5556610A (en) 1992-01-24 1996-09-17 Bracco Research S.A. Gas mixtures useful as ultrasound contrast media, contrast agents containing the media and method
JPH03297475A (en) * 1990-04-16 1991-12-27 Ken Ishihara Controlling method for emission of medicine by means of resonance sound wave
US5514090A (en) 1990-04-24 1996-05-07 Science Incorporated Closed drug delivery system
US5137928A (en) 1990-04-26 1992-08-11 Hoechst Aktiengesellschaft Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents
US5021059A (en) 1990-05-07 1991-06-04 Kensey Nash Corporation Plug device with pulley for sealing punctures in tissue and methods of use
CA2016870C (en) 1990-05-15 1994-03-29 Arnie Drudik Dispenser for storing and mixing several components
US5342394A (en) 1990-05-16 1994-08-30 Olympus Optical Co., Ltd. Apparatus for blocking a vein branch and method of blocking a vein branch
AU636481B2 (en) 1990-05-18 1993-04-29 Bracco International B.V. Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
JP2514087Y2 (en) * 1990-05-25 1996-10-16 幸三 牧田 Balloon with detachable double-sided check valve
US6291605B1 (en) 1990-06-06 2001-09-18 Clarence S. Freeman Polymerization process with spraying step
US5108407A (en) * 1990-06-08 1992-04-28 Rush-Presbyterian St. Luke's Medical Center Method and apparatus for placement of an embolic coil
JP3286315B2 (en) 1990-06-20 2002-05-27 アドバンスト ポリマー システムズ,インコーポレイティド Compositions and methods for controlled release of soluble actives
EP0470569B1 (en) 1990-08-08 1995-11-22 Takeda Chemical Industries, Ltd. Intravascular embolizing agent containing angiogenesis inhibiting substance
US5484584A (en) * 1990-10-02 1996-01-16 Board Of Regents, The University Of Texas System Therapeutic and diagnostic use of modified polymeric microcapsules
US5149543A (en) 1990-10-05 1992-09-22 Massachusetts Institute Of Technology Ionically cross-linked polymeric microcapsules
US5167624A (en) 1990-11-09 1992-12-01 Catheter Research, Inc. Embolus delivery system and method
US5120349A (en) 1990-12-07 1992-06-09 Landec Labs, Inc. Microcapsule having temperature-dependent permeability profile
US5171214A (en) 1990-12-26 1992-12-15 Abbott Laboratories Drug storage and delivery system
US5171217A (en) 1991-02-28 1992-12-15 Indiana University Foundation Method for delivery of smooth muscle cell inhibitors
US5147631A (en) 1991-04-30 1992-09-15 Du Pont Merck Pharmaceutical Company Porous inorganic ultrasound contrast agents
FR2676927B1 (en) 1991-05-29 1995-06-23 Ibf MICROSPHERES FOR USE IN THERAPEUTIC VASCULAR OCCLUSIONS AND INJECTABLE SOLUTIONS CONTAINING THEM.
WO1992021382A1 (en) 1991-06-03 1992-12-10 Holmes, Michael, John Improvements in or relating to contrast agents
GB9116610D0 (en) 1991-08-01 1991-09-18 Danbiosyst Uk Preparation of microparticles
US5216096A (en) 1991-09-24 1993-06-01 Japan Synthetic Rubber Co., Ltd. Process for the preparation of cross-linked polymer particles
US5811447A (en) * 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
CA2079509C (en) 1991-10-01 2002-05-14 Shigeyuki Takada Prolonged release microparticle preparation and production of the same
US5304194A (en) * 1991-10-02 1994-04-19 Target Therapeutics Vasoocclusion coil with attached fibrous element(s)
US5226911A (en) 1991-10-02 1993-07-13 Target Therapeutics Vasoocclusion coil with attached fibrous element(s)
US5256146A (en) 1991-10-11 1993-10-26 W. D. Ensminger Vascular catheterization system with catheter anchoring feature
JP3356447B2 (en) * 1991-10-16 2002-12-16 テルモ株式会社 Vascular lesion embolic material composed of dried polymer gel
US5290310A (en) * 1991-10-30 1994-03-01 Howmedica, Inc. Hemostatic implant introducer
US5411520A (en) 1991-11-08 1995-05-02 Kensey Nash Corporation Hemostatic vessel puncture closure system utilizing a plug located within the puncture tract spaced from the vessel, and method of use
US5234437A (en) 1991-12-12 1993-08-10 Target Therapeutics, Inc. Detachable pusher-vasoocclusion coil assembly with threaded coupling
US5261916A (en) * 1991-12-12 1993-11-16 Target Therapeutics Detachable pusher-vasoocclusive coil assembly with interlocking ball and keyway coupling
US5258042A (en) 1991-12-16 1993-11-02 Henry Ford Health System Intravascular hydrogel implant
EP0625070B1 (en) * 1991-12-20 1998-07-08 AlliedSignal Inc. Low density materials having high surface areas and articles formed therefrom for use in the recovery of metals
US5260002A (en) 1991-12-23 1993-11-09 Vanderbilt University Method and apparatus for producing uniform polymeric spheres
DE69233638T2 (en) 1991-12-24 2007-07-12 E.I. Du Pont De Nemours And Co., Wilmington TWO STABILIZED MICROPARTICLES
GB9200388D0 (en) 1992-01-09 1992-02-26 Nycomed As Improvements in or relating to contrast agents
GB9200391D0 (en) 1992-01-09 1992-02-26 Nycomed As Improvements in or relating to contrast agents
US6537574B1 (en) 1992-02-11 2003-03-25 Bioform, Inc. Soft tissue augmentation material
US5480644A (en) * 1992-02-28 1996-01-02 Jsf Consultants Ltd. Use of injectable biomaterials for the repair and augmentation of the anal sphincters
CN1084410A (en) 1992-03-06 1994-03-30 奈科姆成像有限公司 Relate to the improvement of contrast agent
JP3004724B2 (en) 1992-04-06 2000-01-31 ユーロプラスティ インコーポレイテッド Treatment of reflux obstruction by microparticle injection
EP0565086B1 (en) 1992-04-10 1996-12-27 Mitsubishi Chemical Corporation Method for producing a spherical acrylonitrile crosslinked copolymer
US6235313B1 (en) 1992-04-24 2001-05-22 Brown University Research Foundation Bioadhesive microspheres and their use as drug delivery and imaging systems
US5263964A (en) 1992-05-06 1993-11-23 Coil Partners Ltd. Coaxial traction detachment apparatus and method
AU4198793A (en) * 1992-07-24 1994-01-27 Takeda Chemical Industries Ltd. Microparticle preparation and production thereof
US5292332A (en) * 1992-07-27 1994-03-08 Lee Benjamin I Methods and device for percutanceous sealing of arterial puncture sites
US5807323A (en) 1992-08-13 1998-09-15 Science Incorporated Mixing and delivery syringe assembly
US6592859B1 (en) 1992-08-20 2003-07-15 Ethicon, Inc. Controlled expansion sphincter augmentation media
US5512604A (en) * 1992-08-28 1996-04-30 The Dow Chemical Company Porous copolymers having a cellular polymeric structure suitable for preparing ion-exchange resins and adsorbents
DK0660724T3 (en) * 1992-09-16 1998-11-02 Nycomed Imaging As Preparations for contrast agents
AU4926193A (en) 1992-09-21 1994-04-12 Vitaphore Corporation Embolization plugs for blood vessels
US5312415A (en) * 1992-09-22 1994-05-17 Target Therapeutics, Inc. Assembly for placement of embolic coils using frictional placement
US5350397A (en) * 1992-11-13 1994-09-27 Target Therapeutics, Inc. Axially detachable embolic coil assembly
USRE37117E1 (en) * 1992-09-22 2001-03-27 Target Therapeutics, Inc. Detachable embolic coil assembly using interlocking clasps and method of use
KR960001417B1 (en) 1992-09-26 1996-01-27 한국과학기술원 Method for preparing an improved porous polymer bead
GB9221329D0 (en) * 1992-10-10 1992-11-25 Delta Biotechnology Ltd Preparation of further diagnostic agents
US5382260A (en) * 1992-10-30 1995-01-17 Interventional Therapeutics Corp. Embolization device and apparatus including an introducer cartridge and method for delivering the same
US5369163A (en) 1992-11-13 1994-11-29 Rohm And Haas Company Process for preparing large dimension emulsion polymer particles, polymer product and uses thereof
US5690666A (en) 1992-11-18 1997-11-25 Target Therapeutics, Inc. Ultrasoft embolism coils and process for using them
US5349957A (en) 1992-12-02 1994-09-27 Sterling Winthrop Inc. Preparation and magnetic properties of very small magnetite-dextran particles
US5334216A (en) 1992-12-10 1994-08-02 Howmedica Inc. Hemostatic plug
JP3256583B2 (en) 1992-12-10 2002-02-12 株式会社リコー Electrophotographic toner and method for producing the same
US5288763A (en) * 1992-12-23 1994-02-22 The Johns Hopkins University School Of Medicine Porous, polymer beads and process of their preparation
US6482436B1 (en) 1993-01-29 2002-11-19 Ferx Incorporated Magnetically responsive composition
US5328936A (en) 1993-02-01 1994-07-12 Rohm And Haas Company Polymerization process for making porous polymeric particles
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US5320639A (en) 1993-03-12 1994-06-14 Meadox Medicals, Inc. Vascular plug delivery system
US5925059A (en) 1993-04-19 1999-07-20 Target Therapeutics, Inc. Detachable embolic coil assembly
US5701899A (en) 1993-05-12 1997-12-30 The Board Of Regents Of The University Of Nebraska Perfluorobutane ultrasound contrast agent and methods for its manufacture and use
US5695740A (en) 1993-05-12 1997-12-09 The Board Of Regents Of The University Of Nebraska Perfluorocarbon ultrasound contrast agent comprising microbubbles containing a filmogenic protein and a saccharide
US5567415A (en) 1993-05-12 1996-10-22 The Board Of Regents Of The University Of Nebraska Ultrasound contrast agents and methods for their manufacture and use
US5344867A (en) 1993-06-14 1994-09-06 The Bfgoodrich Company Vinylidene chloride emulsion interpolymer composition
CN100998869A (en) 1993-07-19 2007-07-18 血管技术药物公司 Anti-angiogene compositions and methods of use
US5994341A (en) * 1993-07-19 1999-11-30 Angiogenesis Technologies, Inc. Anti-angiogenic Compositions and methods for the treatment of arthritis
US5398851A (en) * 1993-08-06 1995-03-21 River Medical, Inc. Liquid delivery device
US5397303A (en) * 1993-08-06 1995-03-14 River Medical, Inc. Liquid delivery device having a vial attachment or adapter incorporated therein
US5443495A (en) 1993-09-17 1995-08-22 Scimed Lifesystems Inc. Polymerization angioplasty balloon implant device
US5531716A (en) 1993-09-29 1996-07-02 Hercules Incorporated Medical devices subject to triggered disintegration
US5556391A (en) 1993-10-01 1996-09-17 Merocel Corporation Surgical sponge device
DE1258262T1 (en) * 1993-10-28 2003-04-10 Medrad Inc Contrast delivery system
AU679295B2 (en) 1993-12-15 1997-06-26 Bracco Suisse S.A. Gas mixtures useful as ultrasound contrast media
US5885547A (en) * 1994-01-21 1999-03-23 Paragon Medical Ltd. Particulate material
US5569468A (en) 1994-02-17 1996-10-29 Modi; Pankaj Vaccine delivery system for immunization, using biodegradable polymer microspheres
US5417982A (en) 1994-02-17 1995-05-23 Modi; Pankaj Controlled release of drugs or hormones in biodegradable polymer microspheres
DE69505949T2 (en) 1994-02-17 1999-06-02 Pankaj Modi MEDICINAL PRODUCTS, VACCINE AND HORMONE IN POLYLACTIDE-COATED MICROPARTICLES
AU705305B2 (en) 1994-03-18 1999-05-20 Cook Medical Technologies Llc Helical embolization coil
US5431174A (en) 1994-04-04 1995-07-11 Via Medical Corporation Method of fluid delivery and collection
WO1995029661A1 (en) 1994-04-28 1995-11-09 Primed Halberstadt Medizintechnik Gmbh One-piece dispensing device for the contamination-free administration of medicaments (cytostatica)
US5534589A (en) 1994-05-04 1996-07-09 Minnesota Mining And Manufacturing Company Repulpable plastic films
WO1995031485A1 (en) 1994-05-15 1995-11-23 Pharmacia Biotech Ab A method of manufacturing particles, and particles that can be produced in accordance with the method
JP2535785B2 (en) 1994-06-03 1996-09-18 工業技術院長 Vascular embolic agent
US5583162A (en) 1994-06-06 1996-12-10 Biopore Corporation Polymeric microbeads and method of preparation
US5639710A (en) 1994-07-06 1997-06-17 Zeneca Limited Solid microspheres for agriculturally active compounds and process for their production
ATE207374T1 (en) 1994-08-17 2001-11-15 Boston Scient Corp IMPLANT AND APPLICATION DEVICE
US6099864A (en) 1994-12-02 2000-08-08 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration In situ activation of microcapsules
US5827531A (en) 1994-12-02 1998-10-27 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Microcapsules and methods for making
IL116561A0 (en) 1994-12-30 1996-03-31 Target Therapeutics Inc Severable joint for detachable devices placed within the body
DK175166B1 (en) * 1995-01-03 2004-06-21 Cook William Europ Method of manufacturing an assembly for placing an embolization coil in the vascular system and such assembly as well as an apparatus for advancing the assembly
CA2207667A1 (en) * 1995-01-27 1996-08-01 Scimed Life Systems, Inc. Embolizing system
US6179817B1 (en) * 1995-02-22 2001-01-30 Boston Scientific Corporation Hybrid coating for medical devices
DE69521025T2 (en) 1995-03-07 2001-10-04 Menlo Care Inc Means to improve sphincter function with controlled expansion
US5637087A (en) 1995-03-22 1997-06-10 Abbott Laboratories Prefilled, two-constituent syringe
US5785682A (en) 1995-03-22 1998-07-28 Abbott Laboratories Pre-filled syringe drug delivery system
US5876372A (en) * 1995-03-22 1999-03-02 Abbott Laboratories Syringe system accomodating seperate prefilled barrels for two constituents
US5569193A (en) 1995-03-22 1996-10-29 Abbott Laboratories Syringe system accommodating separately storable prefilled containers for two constituents
US5779668A (en) 1995-03-29 1998-07-14 Abbott Laboratories Syringe barrel for lyophilization, reconstitution and administration
US6638291B1 (en) * 1995-04-20 2003-10-28 Micrus Corporation Three dimensional, low friction vasoocclusive coil, and method of manufacture
US5639277A (en) * 1995-04-28 1997-06-17 Target Therapeutics, Inc. Embolic coils with offset helical and twisted helical shapes
US6428771B1 (en) 1995-05-15 2002-08-06 Pharmaceutical Discovery Corporation Method for drug delivery to the pulmonary system
US6312407B1 (en) 1995-06-05 2001-11-06 Medtronic Percusurge, Inc. Occlusion of a vessel
US5766160A (en) * 1995-06-06 1998-06-16 Target Therapeutics, Inc. Variable stiffness coils
NO962336L (en) * 1995-06-06 1996-12-09 Target Therapeutics Inc Vaso-occlusive spiral
US6214331B1 (en) 1995-06-06 2001-04-10 C. R. Bard, Inc. Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained
US5766147A (en) 1995-06-07 1998-06-16 Winfield Medical Vial adaptor for a liquid delivery device
US5657756A (en) 1995-06-07 1997-08-19 Ctf Systems Inc. Method and systems for obtaining higher order gradiometer measurements with lower order gradiometers
US6013084A (en) * 1995-06-30 2000-01-11 Target Therapeutics, Inc. Stretch resistant vaso-occlusive coils (II)
US6143211A (en) 1995-07-21 2000-11-07 Brown University Foundation Process for preparing microparticles through phase inversion phenomena
US5840387A (en) 1995-07-28 1998-11-24 Aegis Biosciences L.L.C. Sulfonated multiblock copolymer and uses therefor
US6096344A (en) 1995-07-28 2000-08-01 Advanced Polymer Systems, Inc. Bioerodible porous compositions
US5877224A (en) * 1995-07-28 1999-03-02 Rutgers, The State University Of New Jersey Polymeric drug formulations
US5558822A (en) 1995-08-16 1996-09-24 Gas Research Institute Method for production of spheroidized particles
US5888546A (en) * 1995-08-28 1999-03-30 The Regents Of The University Of California Embolic material for endovascular occlusion of abnormal vasculature and method for using the same
US5833361A (en) 1995-09-07 1998-11-10 Funk; James E. Apparatus for the production of small spherical granules
CA2161863A1 (en) 1995-10-31 1997-05-01 Michael Vivian Sefton Angiogenic material and uses thereof
US5752974A (en) 1995-12-18 1998-05-19 Collagen Corporation Injectable or implantable biomaterials for filling or blocking lumens and voids of the body
PT928182E (en) 1996-01-11 2002-10-31 Duoject Inc DISTRIBUTION SYSTEM FOR PHARMACEUTICAL PRODUCTS PACKED IN PHARMACEUTICAL BOTTLES
US5749894A (en) * 1996-01-18 1998-05-12 Target Therapeutics, Inc. Aneurysm closure method
US5702361A (en) * 1996-01-31 1997-12-30 Micro Therapeutics, Inc. Method for embolizing blood vessels
US5895398A (en) * 1996-02-02 1999-04-20 The Regents Of The University Of California Method of using a clot capture coil
US5649949A (en) * 1996-03-14 1997-07-22 Target Therapeutics, Inc. Variable cross-section conical vasoocclusive coils
US6051247A (en) 1996-05-30 2000-04-18 University Of Florida Research Foundation, Inc. Moldable bioactive compositions
US5855615A (en) * 1996-06-07 1999-01-05 Menlo Care, Inc. Controller expansion sphincter augmentation media
US5792478A (en) 1996-07-08 1998-08-11 Advanced Uro Science Tissue injectable composition and method of use
US5980514A (en) * 1996-07-26 1999-11-09 Target Therapeutics, Inc. Aneurysm closure device assembly
US5741331A (en) * 1996-07-29 1998-04-21 Corvita Corporation Biostable elastomeric polymers having quaternary carbons
US5695480A (en) 1996-07-29 1997-12-09 Micro Therapeutics, Inc. Embolizing compositions
US5830178A (en) 1996-10-11 1998-11-03 Micro Therapeutics, Inc. Methods for embolizing vascular sites with an emboilizing composition comprising dimethylsulfoxide
TW421658B (en) 1996-07-31 2001-02-11 Kanebo Ltd Porious spherical particles and the preparation process for preparing thereof
US5823198A (en) 1996-07-31 1998-10-20 Micro Therapeutics, Inc. Method and apparatus for intravasculer embolization
US5813411A (en) 1996-08-20 1998-09-29 Menlo Care, Inc. Method of deforming tissue with a swollen hydrogel
US5902832A (en) 1996-08-20 1999-05-11 Menlo Care, Inc. Method of synthesizing swollen hydrogel for sphincter augmentation
US5785642A (en) 1996-10-18 1998-07-28 Micro Therapeutics, Inc. Methods for treating urinary incontinence in mammals
US6984240B1 (en) * 1996-10-25 2006-01-10 Target Therapeutics, Inc. Detachable multidiameter vasoocclusive coil
US6139963A (en) 1996-11-28 2000-10-31 Kuraray Co., Ltd. Polyvinyl alcohol hydrogel and process for producing the same
US5800454A (en) 1997-03-17 1998-09-01 Sarcos, Inc. Catheter deliverable coiled wire thromboginic apparatus and method
US6090800A (en) * 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
EP1009684B1 (en) 1997-04-10 2005-09-21 The Johns Hopkins University Gas syringe and package therefor
US6056844A (en) 1997-06-06 2000-05-02 Triton Systems, Inc. Temperature-controlled induction heating of polymeric materials
EP0989870A4 (en) * 1997-06-13 2000-08-30 Micro Therapeutics Inc Contoured syringe and novel luer hub and methods for embolizing blood vessels
US6048908A (en) 1997-06-27 2000-04-11 Biopore Corporation Hydrophilic polymeric material
US5959073A (en) 1997-07-07 1999-09-28 Southwest Research Institute Method for preparing polymeric beads
US6056721A (en) 1997-08-08 2000-05-02 Sunscope International, Inc. Balloon catheter and method
WO1999011191A1 (en) 1997-08-28 1999-03-11 Boston Scientific Corporation System for implanting a cross-linked polysaccharide fiber and methods of forming and inserting the fiber
US6476069B2 (en) 1997-09-11 2002-11-05 Provasis Therapeutics Inc. Compositions for creating embolic agents and uses thereof
US6538026B1 (en) 1997-09-11 2003-03-25 Provasis Therapeutics, Inc. Compositions useful for remodeling body spaces
CA2307764A1 (en) 1997-11-07 1999-05-20 Salviac Limited Implantable occluder devices for medical use
US5951160A (en) 1997-11-20 1999-09-14 Biomet, Inc. Method and apparatus for packaging, mixing and delivering bone cement
US6019750A (en) 1997-12-04 2000-02-01 Baxter International Inc. Sliding reconstitution device with seal
US6136015A (en) * 1998-08-25 2000-10-24 Micrus Corporation Vasoocclusive coil
US6159165A (en) * 1997-12-05 2000-12-12 Micrus Corporation Three dimensional spherical micro-coils manufactured from radiopaque nickel-titanium microstrand
US6346091B1 (en) 1998-02-13 2002-02-12 Stephen C. Jacobsen Detachable coil for aneurysm therapy
HU222543B1 (en) 1998-02-23 2003-08-28 Massachusetts Institute Of Technology Biodegradable shape memory polymers
PL342996A1 (en) 1998-02-23 2001-07-16 Mnemoscience Gmbh Shape memory polymers
US6003566A (en) 1998-02-26 1999-12-21 Becton Dickinson And Company Vial transferset and method
US6059766A (en) 1998-02-27 2000-05-09 Micro Therapeutics, Inc. Gynecologic embolotherapy methods
US6047861A (en) 1998-04-15 2000-04-11 Vir Engineering, Inc. Two component fluid dispenser
US6224794B1 (en) 1998-05-06 2001-05-01 Angiotech Pharmaceuticals, Inc. Methods for microsphere production
US6224630B1 (en) 1998-05-29 2001-05-01 Advanced Bio Surfaces, Inc. Implantable tissue repair device
WO1999062432A1 (en) 1998-06-04 1999-12-09 New York University Endovascular thin film devices and methods for treating and preventing stroke
US6267154B1 (en) 1998-06-05 2001-07-31 Abbott Laboratories System for storing mixing and administering a drug
US6165193A (en) 1998-07-06 2000-12-26 Microvention, Inc. Vascular embolization with an expansible implant
US6264861B1 (en) 1998-08-05 2001-07-24 Xeikon Nv Method for producing rounded polymeric particles
US6315709B1 (en) 1998-08-07 2001-11-13 Stereotaxis, Inc. Magnetic vascular defect treatment system
US6152943A (en) 1998-08-14 2000-11-28 Incept Llc Methods and apparatus for intraluminal deposition of hydrogels
US6296622B1 (en) 1998-12-21 2001-10-02 Micrus Corporation Endoluminal device delivery system using axially recovering shape memory material
CA2248592A1 (en) 1998-08-31 2000-02-29 Christopher D. Batich Microspheres for use in the treatment of cancer
AU6288799A (en) * 1998-10-09 2000-05-01 Cook Incorporated Vasoocclusion coil device having a core therein
FR2784580B1 (en) * 1998-10-16 2004-06-25 Biosepra Inc POLYVINYL-ALCOHOL MICROSPHERES AND METHODS OF MAKING THE SAME
US6238335B1 (en) 1998-12-11 2001-05-29 Enteric Medical Technologies, Inc. Method for treating gastroesophageal reflux disease and apparatus for use therewith
JP2000189511A (en) 1998-12-25 2000-07-11 Kaneka Medeikkusu:Kk Embolization material
US6162377A (en) 1999-02-23 2000-12-19 Alberta Research Council Inc. Apparatus and method for the formation of uniform spherical particles
US6296604B1 (en) 1999-03-17 2001-10-02 Stereotaxis, Inc. Methods of and compositions for treating vascular defects
US6368658B1 (en) 1999-04-19 2002-04-09 Scimed Life Systems, Inc. Coating medical devices using air suspension
US6280457B1 (en) 1999-06-04 2001-08-28 Scimed Life Systems, Inc. Polymer covered vaso-occlusive devices and methods of producing such devices
JP2001079011A (en) 1999-09-14 2001-03-27 Akira Morimoto Embolization coil and its manufacture
US6277392B1 (en) 1999-09-16 2001-08-21 Carbon Medical Technologies, Inc. Tissue injectable composition
US6602261B2 (en) 1999-10-04 2003-08-05 Microvention, Inc. Filamentous embolic device with expansile elements
US6238403B1 (en) 1999-10-04 2001-05-29 Microvention, Inc. Filamentous embolic device with expansible elements
US6790218B2 (en) 1999-12-23 2004-09-14 Swaminathan Jayaraman Occlusive coil manufacture and delivery
KR100335866B1 (en) * 2000-01-06 2002-05-10 박호군 Microspheric Embolic Materials Having Duel Structure of Poly(Vinyl Acetate) Core/Poly(Vinyl Alcohol) Shell, and Method for Preparing The Same
US6306419B1 (en) 2000-02-23 2001-10-23 Aegis Biosciences, Llc Medical uses of styrene sulfonate polymers
JP2003525682A (en) 2000-03-06 2003-09-02 シメッド ライフ システムズ インコーポレイテッド Embolic agent visible under ultrasound
US6652883B2 (en) 2000-03-13 2003-11-25 Biocure, Inc. Tissue bulking and coating compositions
DE60130544T2 (en) 2000-03-13 2008-06-26 Biocure, Inc. EMBOLIC COMPOSITIONS
US6423332B1 (en) 2000-05-26 2002-07-23 Ethicon, Inc. Method and composition for deforming soft tissues
DE10026620A1 (en) 2000-05-29 2002-03-07 Gerhard Quelle Biocompatible material for cell and tissue implantation, useful e.g. for drug release or cosmetic tissue augmentation, consisting of spherical particles having (semi-)permeable or porous outer shell and internal cavity
US6355275B1 (en) * 2000-06-23 2002-03-12 Carbon Medical Technologies, Inc. Embolization using carbon coated microparticles
JP2002017848A (en) 2000-07-12 2002-01-22 Terumo Corp Intravitally injectable particulate and method for preparing the same
US6394965B1 (en) 2000-08-15 2002-05-28 Carbon Medical Technologies, Inc. Tissue marking using biocompatible microparticles
US7029486B2 (en) * 2000-09-26 2006-04-18 Microvention, Inc. Microcoil vaso-occlusive device with multi-axis secondary configuration
AUPR098200A0 (en) 2000-10-25 2000-11-16 Sirtex Medical Limited Production of low density radionuclide containing microspheres
AUPR098300A0 (en) * 2000-10-25 2000-11-16 Sirtex Medical Limited Polymer based radionuclide containing microspheres
US6545097B2 (en) 2000-12-12 2003-04-08 Scimed Life Systems, Inc. Drug delivery compositions and medical devices containing block copolymer
US6669652B2 (en) 2000-12-21 2003-12-30 Advanced Cardiovascular Systems, Inc. Guidewire with tapered distal coil
US6632531B2 (en) 2001-02-15 2003-10-14 Rohm And Haas Company Porous particles, their aqueous dispersions, and method of preparation
US20030032935A1 (en) * 2001-08-10 2003-02-13 Scimed Life Systems, Inc. Packages facilitating convenient mixing and delivery of liquids
US20030120302A1 (en) * 2001-12-20 2003-06-26 Scimed Life Systems, Inc. Vaso-occlusive device with serpentine shape
US7218962B2 (en) 2002-03-29 2007-05-15 Boston Scientific Scimed, Inc. Magnetically enhanced injection catheter
US7131997B2 (en) 2002-03-29 2006-11-07 Scimed Life Systems, Inc. Tissue treatment
US7462366B2 (en) 2002-03-29 2008-12-09 Boston Scientific Scimed, Inc. Drug delivery particle
US7094369B2 (en) 2002-03-29 2006-08-22 Scimed Life Systems, Inc. Processes for manufacturing polymeric microspheres
US7053134B2 (en) 2002-04-04 2006-05-30 Scimed Life Systems, Inc. Forming a chemically cross-linked particle of a desired shape and diameter
US7838699B2 (en) 2002-05-08 2010-11-23 Biosphere Medical Embolization using degradable crosslinked hydrogels
WO2004011076A2 (en) 2002-07-25 2004-02-05 Boston Scientific Limited Medical device for navigation through anatomy and method of making same
US20040076582A1 (en) 2002-08-30 2004-04-22 Dimatteo Kristian Agent delivery particle
US7449236B2 (en) 2002-08-09 2008-11-11 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US8012454B2 (en) 2002-08-30 2011-09-06 Boston Scientific Scimed, Inc. Embolization
US7588825B2 (en) 2002-10-23 2009-09-15 Boston Scientific Scimed, Inc. Embolic compositions
US7883490B2 (en) 2002-10-23 2011-02-08 Boston Scientific Scimed, Inc. Mixing and delivery of therapeutic compositions
US20040115164A1 (en) 2002-12-17 2004-06-17 Pierce Ryan K. Soft filament occlusive device delivery system
US20040153025A1 (en) * 2003-02-03 2004-08-05 Seifert Paul S. Systems and methods of de-endothelialization
US7792568B2 (en) 2003-03-17 2010-09-07 Boston Scientific Scimed, Inc. MRI-visible medical devices
US7906148B2 (en) * 2003-07-31 2011-03-15 Boston Scientific Scimed, Inc. Latex medical articles for release of antimicrobial agents
US20050037047A1 (en) * 2003-08-11 2005-02-17 Young-Ho Song Medical devices comprising spray dried microparticles
US7976823B2 (en) 2003-08-29 2011-07-12 Boston Scientific Scimed, Inc. Ferromagnetic particles and methods
US7901770B2 (en) 2003-11-04 2011-03-08 Boston Scientific Scimed, Inc. Embolic compositions
US7736671B2 (en) 2004-03-02 2010-06-15 Boston Scientific Scimed, Inc. Embolization
US8173176B2 (en) 2004-03-30 2012-05-08 Boston Scientific Scimed, Inc. Embolization
US20050238870A1 (en) 2004-04-22 2005-10-27 Marcia Buiser Embolization
US7311861B2 (en) 2004-06-01 2007-12-25 Boston Scientific Scimed, Inc. Embolization
US20060045900A1 (en) * 2004-08-27 2006-03-02 Robert Richard Embolization
US8425550B2 (en) 2004-12-01 2013-04-23 Boston Scientific Scimed, Inc. Embolic coils
US7858183B2 (en) 2005-03-02 2010-12-28 Boston Scientific Scimed, Inc. Particles
US7727555B2 (en) 2005-03-02 2010-06-01 Boston Scientific Scimed, Inc. Particles
US7963287B2 (en) 2005-04-28 2011-06-21 Boston Scientific Scimed, Inc. Tissue-treatment methods
US20070004973A1 (en) 2005-06-15 2007-01-04 Tan Sharon M L Tissue treatment methods
US9463426B2 (en) 2005-06-24 2016-10-11 Boston Scientific Scimed, Inc. Methods and systems for coating particles
US20070083219A1 (en) 2005-10-12 2007-04-12 Buiser Marcia S Embolic coil introducer sheath locking mechanisms

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994069A (en) 1988-11-02 1991-02-19 Target Therapeutics Vaso-occlusion coil and method
US5304195A (en) 1991-12-12 1994-04-19 Target Therapeutics, Inc. Detachable pusher-vasoocclusive coil assembly with interlocking coupling
US5250071A (en) 1992-09-22 1993-10-05 Target Therapeutics, Inc. Detachable embolic coil assembly using interlocking clasps and method of use
WO1994006503A1 (en) * 1992-09-22 1994-03-31 Target Therapeutics, Inc. Detachable embolic coil assembly
US5800453A (en) 1993-04-19 1998-09-01 Target Therapeutics, Inc. Detachable embolic coil assembly using interlocking hooks and slots
US5800455A (en) 1993-04-19 1998-09-01 Target Therapeutics, Inc. Detachable embolic coil assembly
US6231586B1 (en) 1995-06-06 2001-05-15 Target Therapeutics, Inc. Three dimensional in-filling vaso-occlusive coils
US6322576B1 (en) 1997-08-29 2001-11-27 Target Therapeutics, Inc. Stable coil designs
US6159206A (en) * 1997-10-30 2000-12-12 Kaneka Medix Corporation Medical implement for depositing implanted device and method of depositing implanted device
WO1999042038A1 (en) * 1998-02-18 1999-08-26 Boston Scientific Limited Vaso-occlusive member assembly with multiple detaching points
WO2000053105A1 (en) * 1999-03-09 2000-09-14 Micrus Corporation Shape memory segmented detachable coil
US6635069B1 (en) 2000-10-18 2003-10-21 Scimed Life Systems, Inc. Non-overlapping spherical three-dimensional coil

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017039672A1 (en) * 2015-09-03 2017-03-09 Elenza, Inc. Rechargeable intraocular implant
US10813744B2 (en) 2015-09-03 2020-10-27 Greatbatch Ltd. Rechargeable intraocular implant
WO2018195236A1 (en) * 2017-04-19 2018-10-25 Boston Scientific Scimed, Inc. Variable length vascular occlusion system
AU2018256401B2 (en) * 2017-04-19 2020-01-23 Boston Scientific Scimed, Inc. Variable length vascular occlusion system
US11191927B2 (en) 2017-07-31 2021-12-07 Boston Scientific Scimed, Inc. Dilator with engagement region
US11000287B2 (en) 2017-08-15 2021-05-11 Boston Scientific Scimed, Inc. Occlusive medical device system
US10874402B2 (en) 2017-10-10 2020-12-29 Boston Scientific Scimed, Inc. Detachable RF energized occlusive device
US11154412B2 (en) 2018-02-01 2021-10-26 Boston Scientific Scimed, Inc. Medical device release system
US11284902B2 (en) 2018-02-01 2022-03-29 Boston Scientific Scimed, Inc. Method of making a vascular occlusion device
US11672946B2 (en) 2019-09-24 2023-06-13 Boston Scientific Scimed, Inc. Protection and actuation mechanism for controlled release of implantable embolic devices

Also Published As

Publication number Publication date
US20070083226A1 (en) 2007-04-12
US8007509B2 (en) 2011-08-30

Similar Documents

Publication Publication Date Title
US8007509B2 (en) Coil assemblies, components and methods
US11627950B2 (en) Micrograft for the treatment of intracranial aneurysms and method for use
US20240033110A1 (en) Vascular implant
US11786255B2 (en) Packaging for surgical implant
US10420563B2 (en) Delivery system insertable through body lumen
US11779452B2 (en) Vascular implant

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06816221

Country of ref document: EP

Kind code of ref document: A1